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ABSTRACT 
 
The field of organ and tissue transplantation has necessitated an improved 
understanding of their associated pathophysiological pathways. Specific 
areas of interest involve the changes that follow ischaemia and 
derangement’s that accompany organ and tissue storage, reperfusion injury 
and the “no-reflow” phenomenon. Strategies have been devised to 
manipulate and modify these processes, improving tissue and organ survival 
and function. These have involved the use of preservation solutions. 
Although most research involves organ transplantation, these principles have 
been translated and applied to various tissues, surgical flaps and 
microvascular replantations. These studies have generally used the skin flap 
as their model with little knowledge regarding muscle flaps, the most 
vulnerable to the ischaemic process. This study targets the use of one such 
preservation system and uses skeletal muscle as its tissue model. 
The vascular anatomy of the rectus femoris muscle in the New Zealand 
white rabbit was studied anatomically and radiologically and thus described. 
The isolated rectus femoris muscle flap was harvested and perfused in-vitro 
with cooled, oxygenated University of Wisconsin solution (UWS) using a 
pulsatile renal perfusion pump. UWS was selected as it contains vital 
additives important in cryopreservation of organs. Monitoring of various 
physiological parameters was performed. The muscle was examined at 0, 4, 
8, 12, 18 and 24 hours of extra-corporeal perfusion using warm and cold, 
non-perfused controls. The contralateral muscle served as the control. 
End-points were the percentage of muscle survival, as determined by a new 
grading system of muscle ischaemia, based on 3 light and 7 electron 
microscopic criteria.  
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The overall percentage of muscle survival (combined light and electron 
microscopy scores) resulted in approximately 58% survival at 24 hours for 
the perfused muscle versus 31% for the cold stored muscle. The stored 
muscle had the same survival rate at 12 hours as did the perfused muscle at 
24 hours. For all time periods beyond 4 to 8 hours, perfused muscle showed 
statistically improved survival rates compared to the stored muscle.  Eight 
hours appears to be a crucial point beyond which survival in muscle 
deteriorates to a much greater degree without perfusion. 
 
Questions remain as to which method of preservation yields the best survival 
benefit and, as yet, there is no “ideal” perfusate.  The future involves 
manipulating perfusion solutions and trying to arrest or reverse established 
warm ischaemia. Success of free tissue transfers and replantations of muscle-
containing body parts may be enhanced. These techniques may also allow us 
to effectively store previously harvested flaps and eventually, to enter the 
realm of “banked” allograft tissue flaps. 
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PREFACE 
 
The advent of microsurgery has revolutionised reconstructive plastic surgery. 
The microsurgical approach to clinical problems no longer lies at the top of 
the "reconstructive ladder" -  in many instances, these methods provide the 
best first-line option. In recent years, reconstructive microsurgery has 
evolved to "state-of-the-art" in solving a variety of reconstructive problems.  
These innovative procedures have been fraught by such problems of 
ischaemia and  the reconstructive surgeon has become increasingly 
concerned with their pathophysiology and its management. 
 
Other areas of interest include the changes that occur with hypothermia and 
storage, reperfusion injury and the “ no-reflow”  phenomenon. Flap failure 
due to extrinsic or mechanical causes has become less common, yet intrinsic 
biochemical causes continue to be problematic ( Mellow et al,1990). 
The elucidation of various methods of intervention to prolong the survival of 
skin, muscle flaps or muscle-containing amputated parts after an ischaemic 
event has and continues to be a challenging area of research. This may save 
such tissue from ischaemia-reperfusion injury and prolong ischaemic 
survival and ultimately, function of the surviving replanted part / flap.  
 
The death of cells is a complicated process which may proceed in a 
reasonably ordered fashion, depending on the cause. The early 
histopathological changes accompanying the necrosis of ischaemic skeletal 
muscle needs to be accurately defined. The correlation of these changes with 
the times to loss of viability is of critical importance.  
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If one can accurately and quantitatively assess these alterations during the 
early, reversible phases before the onset of the "no-reflow" phenomenon 
(May et al, 1978; Chait, 1978), one could intervene either mechanically or 
pharmacologically  to prevent progression to irreversible cell death 
(Harishima & Buncke, 1975; Gould, 1985; Rosen et al,1985; Pang,1989; 
Knight et al,1991; Kriedstein et al,1991; Mellow et al,1990; Gordon et 
al,1992; Morris et al,1993). Perhaps, by carefully identifying the critical 
point of transition from reversibility to an irreversible situation, one may be 
able to intervene so as to salvage otherwise irreparably damaged tissues. The 
results of such interventions are at times, difficult to interpret. This is due to 
varying animal models and the protean pharmacological and other 
therapeutic interventions.  
 
Although many reports appear in the literature concerning creation and 
maintenance of microvascular anastomoses and extensive research into the 
pharmacological manipulation of transplanted tissues, a uniform, 
standardised and quantitative grading system of ischaemic muscle still 
appears to be lacking. Further objectives of this study include an attempt to 
provide an overall, simple and quantitative grading system which unifies 
well- known histopathological and ultrastructural features of ischaemic 
damage to skeletal muscle. It also provides for early detection of potentially 
reversible changes. 
 
In an attempt to find an "ideal" perfusate solution that could be used in this 
study, a review of the literature showed that most work in this field was 
performed on organ preservation. Preservation of any organ (or tissue) 
therefore hinges on two essential strategies (Southard & Belzer, 1993): 
(1) cooling of the structure and (2) the use of preservative solutions. 
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The latter may be used as a simple immersion cryopreservative or as more 
complex perfusion systems. Therefore organ and tissue preservation and 
more especially using cold preservative solutions (cryopreservation), is an 
important area of study. 
  
With developing expertise however, it has become clear that different tissues 
have different metabolic requirements and ischaemic profiles and that 
solutions of different compositions are required for different tissues (Belzer 
& Southard, 1988; Kohout et al, 1995). A solution suitable for liver 
preservation may quite different from that required by kidney, skin or 
muscle. The current literature shows a paucity in the study of isolated 
muscle ischaemia and preservation of muscle flaps. Considering that this 
tissue is uniquely and exquisitely sensitive to ischaemia and its effects 
(Toutas & Bergman, 1977; Sjostrom et al, 1982; Chachques et al, 1985; 
Harris et al,1986; Gregory & Mars, 1992; Hickey et al, 1992) and the 
commonplace use of muscle in tissue transplantation, this tissue was 
therefore a logical choice in  a study involving cryopreservation of ischaemic 
tissue.  
 
Having decided on a perfusion solution (in this case, using a standard organ 
preservation solution known to limit ischaemic cellular damage - University 
of Wisconsin solution or UWS) and an appropriately ischaemically-prone 
tissue (in this case, skeletal muscle), one had to consider the method of 
delivery of UWS to the muscle. The methods now used for organ 
preservation prior to transplantation are simple flush, cold storage immersion 
or pulsatile perfusion by means of a mechanical pump.  
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Waugh et al (2000) studied the effects of pre-ischaemic perfusion of rat 
skeletal muscle flaps with perfusion solutions delivered by means of 
mechanical flush with uncontrolled pressures.  
Yokoyama et al (1996) compared rat whole –limb viability after cold 
immersion in UWS or Euro-Collins solution. Hickey et al (1995) 
investigated the effects of simple flush of phosphoenolpyruvate / ATP 
solution of rabbit muscle flaps. Li et al (1993) decreased the ischaemia / 
reperfusion injury of rat muscle flaps with anticoagulated blood, again 
delivered by simple flush. 
  
A review of the current literature (English language) appears to show that 
there are no available studies regarding the use of perfusion of an isolated 
skeletal muscle flap delivered in a pulsatile fashion. This method of delivery 
was chosen as it was felt it is the most physiological method of delivery of 
perfusate.  The experimental design in this study therefore involves extra-
corporeal perfusion isolated skeletal muscle in a pulsatile fashion with 
cooled oxygenated University of Wisconsin solution over a period of 24 
hours, using a mechanical pump, in this case a “ Waters Instruments Mox 
100”  renal perfusion pump. End-points of ischaemic damage using the 
proposed ischaemic grading system are characterised and an analysis made 
of the critical "point of no return" after which irreversible ischaemic changes 
occur. 
 
The HYPOTHESIS that this study will attempt to address is therefore as 
follows: 
“perfusion of an isolated skeletal muscle flap with cooled, oxygenated 
University of Wisconsin solution prolongs ischaemic survival.”  
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As our knowledge continues to improve, the possibility of intervention by 
mechanical or pharmacological means may have tremendous clinical impetus 
in terms of overall survival and improved muscle function, especially post-
replantation of muscle-containing amputated body parts.  
Even in the most experienced of hands, this procedure is enshrouded with 
the danger of failure of the replanted part to survive or to function adequately 
post-replantation due to muscle necrosis and subsequent replacement 
fibrosis. 
 In attempting to improve and prolong muscle flap ischaemic survival time, 
this study may be extrapolated to the clinical situation outlined above. 
  
During the inevitable delay prior to replantation, it is hoped that, by  
attaching amputated body parts to a mechanical pump and perfusing it with a 
similar solution used in this study, beneficial effects regarding survival of the 
part will be achieved. Further applicability may, in the future, be translated 
to the potential field of tissue storage using “ banked”  allograft tissue flaps. 
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CHAPTER 1 -  INTRODUCTION 
 
1.1. SCOPE AND OBJECTIVES OF THE STUDY 
 
1. To determine the vascular anatomy of the rectus femoris muscle in the 
New Zealand White rabbit. This will be performed by means of anatomical 
dissection and radiographic studies. 
2. To review the literature and formulate a new grading system of muscle 
ischaemia. 
3. Following the description of the rectus femoris  muscle flap, perform 
various manipulations in order to investigate various questions relating to 
muscle ischaemia and organ preservation solutions as follows: 
• create a statistical control group by storage of the flap under 
normothermic (25 0C) and hypothermic (4 0C) conditions. 
• confirm that cold storage of muscle delays the ischaemic process. 
•  determine if perfusion of the muscle flap can prolong ischaemic survival 
time using  cooled, oxygenated University of Wisconsin solution (UWS). 
• determine if  ischaemic events occurring in the muscle flap can be 
influenced. 
4. To add to the body of knowledge of ischaemic-reperfusion injury in 
skeletal muscle and the effects of cryopreservation solutions on ischaemic 
damage. 
5. To gain experience with current practices regarding organ preservation 
solutions. 
6.  To add to the body of knowledge in the field of tissue preservation,  
muscle flaps and  microsurgery. 
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1.2. POTENTIAL SIGNIFICANCE 
 
1. The development of a working animal model that provides a relatively 
simple and reliable skeletal muscle flap. This may then be employed for  
further study regarding various manipulations of the flap and their effects on 
muscle. 
2. The establishment of an "ideal" muscle perfusate which may significantly  
improve ischaemic skeletal muscle survival. 
3. If perfusion of muscle flaps can be shown to prolong ischaemic survival 
time, then perfusion of amputated parts containing muscle (which have a 
shorter critical ischaemic time than skin), may result in improved survival of 
such parts post-replantation and transplantation. 
4. The development of an effective, readily transportable and simple method 
of perfusion of muscle-containing amputated parts. This may be used in the 
clinical situation so that such parts may be perfused  during inevitable delays 
prior to replantation. 
5. To reduce the effects of established ischaemic damage and reperfusion 
injury so as to improve overall survival of myocytes. 
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 1.3. ANATOMICAL STUDIES 
 
  1.3.1.  Anatomy of the Rectus femoris  Muscle Flap in the Rabbit and its 
Vascular Supply 
 
A primary aim of this study is to elucidate the effects of an organ perfusion 
solution on isolated skeletal muscle subjected to various intervals of 
ischaemia. Before this aspect of the study could be addressed, it was 
essential  to have an available animal model of a skeletal muscle flap.  
 
The criteria of this flap were to be as follows: 
1. easily available small laboratory animal – New Zealand white rabbit 
2. isolated skeletal muscle, available bilaterally – rectus femoris muscle 
3. established vascular anatomy /pattern  
4. reliable and documented vascular pedicle to muscle 
5. vessels of calibre compatible for microvascular surgery (if necessary) 
6. easy dissection 
 
Limb surgery, particularly that involving the use of surgical flaps, demands 
an understanding of vascular anatomy. Knowledge of its vascular pedicle 
allows a flap to be raised as an isolated pedicled or even a free flap, so that 
further research manipulation may take place. This is important for a number 
of reasons: 
1. blood flow in the pedicle can then be controlled and the artery may be 
canulated for measurement of intra-arterial pressures.  
2. the vascular pedicle also provides a convenient entry point for perfusion 
of the flap with pharmacological solutions. 
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3.  during studies on ischaemia-reperfusion injury, the isolated pedicle may 
be clamped thus avoiding the crush injury produced by traditional hindlimb 
tourniquet methods.  
4. as a free flap, a muscle may manipulated as required then elevated and 
micro-anastomosed to the contra - lateral vessels, allowing for a new vista of 
research information. 
 
It is therefore pertinent to have an accurate description of the blood supply of 
the rectus femoris muscle in this animal model. A search of available 
veterinary literature as well as direct communications with veterinarians 
showed a surprising dearth of adequate descriptions of lower limb vascular 
anatomy in the rabbit. Descriptions included the gross and overall structural 
layout of the vascular system, but anatomical dissections were inadequate / 
unavailable for a detailed appraisal of the regional vascularity. A review of 
the medical literature only provided general descriptions of rat, feline or 
canine hindlimb animal models (Kuzon et al, 1986).  
 
The rectus femoris muscle flap model in the rabbit has been described 
previously and has proven to be technically feasible, safe and reliable 
(Guelinckx et al, 1988; Guelinckx & Faulkner, 1992). Hickey et al (1992) 
also  describe the basic surgical procedure of elevating the rectus femoris 
flap in this animal. These authors however, do not detail the vascular or 
gross anatomy of the flap.  
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1.3.2. Angiographic Studies  
 
An extensive and detailed angiographic study of the rabbit lower limb has 
been described by McNally et al (1992). They performed high quality 
arteriographies in normal, un-operated rabbits with a view to understanding 
variations in vascular anatomy. 
No specific reference was made as to the vascular anatomy of skeletal 
including that of the rectus femoris muscles.  
 
A further aim of this study will be to document the regional vascular 
anatomy in the groin and lower limb region in the rabbit as seen on contrast 
angiogram and to demonstrate the vascular pedicle to the rectus femoris 
muscle. It describes in detail the gross anatomy of the rectus femoris flap and 
correlates these findings with that of angiographic studies.  
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1.4. ANALYSIS AND BACKGROUND OF THE STUDY 
 
1.4.1. Ischaemic Changes and Reperfusion Injury 
 
Historically, the problem of Volkmann's ischaemic contracture lead many of 
the earlier investigators to devote their attention to the chronic ischaemic 
changes in skeletal muscle, with little attention to the initial changes that 
occur in the first 24 hours (Brooks,1922; Jepston,1926; Griffiths,1940; 
Clarke,1946). 
Ischaemia may be defined as a blood supply insufficient to meet a tissue’s 
metabolic demands, resulting in hypoxia and accumulation of toxic 
metabolites. This results in compromised cellular integrity and ultimately in 
cell death. During ischaemia, oxygen supply is reduced thus forcing the cell 
to convert to the less efficient anaerobic glycolytic pathway. This results in 
the production of lactic acid thereby lowering the intracellular pH 
(Slater,1984; Swartz et al,1978 ; Chaudry,1983). If hypoxia persists, the 
transmembrane sodium - potassium ATPase pump fails and sodium and 
calcium cations enters the cell. This increases the osmotic pressure and 
produces cellular oedema. ADP is catabolised to adenosine, then 
progressively to inosine, hypoxanthine and xanthine (Figure 1). 
Upon reperfusion and the return of oxygen to the tissues the accumulated 
hypoxanthine is acted upon by xanthine oxidase, converting it to uric acid 
and the toxic superoxide free radical. This is subsequently converted to 
hydrogen peroxide and the highly reactive hydroxyl ion. Other toxic free 
radicals have also been demonstrated. The free radicals thus produced are 
highly unstable and react violently with stable molecules, producing more 
free radicals, thus propagating their effects. Oxygen free radicals in 
ischaemic tissues are generated from a number of differing sources. The 
relative importance of these mechanisms is not known (Kohout et al, 1995). 
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Figure 1: The biochemical pathway for production of oxygen free radicals 
during reperfusion of ischaemic tissue (after Granger et al, 1986) 
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 Regardless of the source, free radicals are toxic to all biological substances, 
including collagen, proteins, polysaccharides and nucleic acids. 
Polyunsaturated fatty acids, components of cell membrane phospholipids, are 
particularly sensitive. Lipid peroxidation of cellular and subcellular 
membranes is postulated to be a direct cause of cell death (Del Maestro, 
1980; Pang, 1990). Free radical injury of the vascular endothelium increases 
vessel wall permeability and causes tissue oedema (McCord,1985). Free 
radicals also affect arachidonic acid cascade and shifts the normal 
prostacycline: thromboxane balance towards production of deleterious 
vasoconstrictor, thromboxane. Neutrophil infiltration and adhesion to the 
endothelium, as well as the release of inflammatory mediators such as 
platelet-activating factor and cytokines, are believed to play major roles in 
the  ischaemia-reperfusion injury (Kerrigan & Stotland, 1993). The resultant 
damaging chain reactions cause thrombosis in macro- and micro-vessels, 
necrosis of endothelial and parenchymal cells and vasoconstriction. This 
results in flap failure or loss of replanted digits or limbs.  
 
Ischaemia and reperfusion in skeletal muscle is unavoidable in many cases of 
vascular disease, musculoskeletal trauma and reconstructive surgery. 
Familiar examples include limb amputation with subsequent replantation, 
revascularisation in cases of peripheral vascular disease after cross clamping 
and in free tissue transfers of muscle flaps. Although skeletal muscle has a 
higher tolerance to ischaemia than some organ systems, it remains highly 
sensitive to cessation of blood supply especially under normothermic 
conditions. Human leg ischaemia of 1 to 2,5 hours duration due to aortic 
cross clamping during reconstructive vascular surgery or tourniquet during 
orthopaedic knee surgery, resulted in significant decline in muscle glycogen 
and phosphocreatine pools. 
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However, this biological damage normalised after 5 minutes following 
reperfusion (Toutas & Bergman, 1977; Sjostrom et al, 1982). Some 
morphological damage , primarily attributable to membrane disturbances, 
was found after 30 minutes of reperfusion, although no histopathological or 
ultrastructural evidence of necrosis was present 5 days post-operatively 
(Sjostrom et al, 1982). 
 
Harris et al (1986), using the canine gracilis muscle model, demonstrated 
some muscle necrosis at 4 hours of warm ischaemia (parameters being both 
biochemical and ultrastructural) and severe injury and necrosis at 7 hours. 
 
Hickey et al (1992) examined the consequences of increasing duration of 
ischaemia to the rectus femoris muscle in the rabbit. Post-ischaemic survival, 
as measured by  Nitro blue tetrazolium (NBT) staining 24 hours after 
normothermic ischaemia showed 91% after 2 hours, 77% after 3 hours, 42% 
after 3,5 hours, 11% after 4 hours and 0,6% after 6 hours.  
 
Chachques et al (1985) subjected rats to hindlimb normothermic tourniquet  
ischaemia of varying intervals as well as increasing periods of reperfusion. 
They documented histological evidence of ischaemic damage after 3 – 6 
hours ischaemia following reperfusion but recovery of the mitochondrial 
respiratory chain after 14 days. This group sustained a reversible injury. The 
second group, subjected to 6 - 9 hours of ischaemia followed by reperfusion 
underwent a transitional course whereas those suffering ischaemia greater 
than 9 hours showed irreversible damage. 
 
 A critical point in time exists when, despite restoration of adequate blood 
flow, irreversible damage has occurred and the transferred tissue fails to 
survive. 
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This is known as  reperfusion injury or the "no-reflow" phenomenon, with 
muscle being especially susceptible (May et al,1978). Reperfusion injury 
thus results in endothelial swelling, vasoconstriction, intravascular sludging 
and microvascular microthrombi formation. These pathophysiologic events 
all contribute to the “ no-reflow”  phenomenon (Chait et al, 1978 ; May et al, 
1978; Weinberg & Song, 1984 ; Douglas et al,1987). 
 
The addition of oxygen is controversial and, in fact, may be deleterious 
(Belzer et al, 1982). From the previous discussion regarding generation of 
free radicals (refer Section 1.4.1.) introduction of oxygen may result the 
generation of toxic 02 free radicals. Some  studies suggest that perfusion 
solutions do not require oxygenation because oxygen levels achieved by air 
equilibration are sufficient for the low metabolic rates during hypothermia 
(Johnson, 1983). Their study was performed on the kidney, an organ which 
has a different metabolic rate to muscle, the latter being a highly aerobic 
tissue.   
 
Various investigators have shown that substrate metabolism (Petterssen et al, 
1974), ATP production (Garvin et al, 1981; Southard, 1984) and active 
cation transport (Burg & Orloff, 1964) continue during hypothermia. The 
provision of oxygen may be beneficial in these scenarios. Other studies have 
demonstrated improved function of kidneys by retrograde persufflation with 
oxygen via the renal vein (Pegg et al, 1989).  
 
The addition of oxygen therefore, remains debatable.  Considering the highly 
aerobic nature of skeletal muscle, it was felt that the addition of oxygen was 
important in this muscle flap model. 
 
 
  
11 
 
11 
Much of the emphasis in organ and tissue transplantation and replantation  
has recently shifted from the problem of surgical technique, now largely 
mastered, to one of preservation. Preservation confers 4 major advantages in 
transplantation (D’Alessandro, 1994):  
 
(1) time to transport the organ or tissue from the donor to the recipient 
hospital 
(2) time to allow tissue matching to be performed 
(3) time to prepare the recipient and surgical team and in the case of 
replantation, to adequately resuscitate the patient 
(4) improved organ or tissue survival and function post-transplantation 
 
Recovery of function depends upon preservation of cellular and organ 
integrity as well as the ability to restore blood flow. Clearly, our ability to 
alter the progressive effects of reperfusion damage and permit salvage of 
ischaemic tissue, must be based on an understanding of their biochemical 
processes. 
 
Preservation of any tissue hinges on 2 major strategies: 
1. tissue cooling (refer Section 1.4.2) 
2. the use of perfusion solutions which, by nature of their composition, 
minimises the effects of ischaemia and reperfusion injury (refer Section 
1.4.4) 
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 1.4.2. Tissue Cooling -  Hypothermic Storage and Injury During 
Preservation 
 
The beneficial effects of hypothermia on preserving the viability of anoxic 
tissue has long been recognised. As early as 1908, Carrel demonstrated the 
capability of preserving arterial grafts under hypothermic conditions for 
periods of up to 10 days (Carrell, 1908). 
 
A similar understanding applies to muscle-containing free tissue transfers 
and amputated parts. Lapchinsky (1960) presented a long-term series of 
replanted hind limbs of dogs, and described details of limb cooling to 4 oC. 
Usui et al (1978), documented the beneficial effects of hypothermia in limb 
replantation in the human model. Longer periods may be obtained with 
hypothermic preservation. Previous experimental studies of free groin flaps 
in rabbits, supported by upwards of 72 hours of hypothermia, have 
demonstrated evidence of tissue survival (Donski et al,1980) while 
successful experimental limb replantation has been achieved after 108 hours 
of supplemental hypothermia (Lapchinsky, 1960; Tsu-Min Tsai et al, 1982).  
 
It is generally accepted that tissue cooling universally improves the viability 
of explanted tissue by slowing down the metabolic processes and is therefore 
used in all the currently employed protocols (Kohout et al, 1995).  
Belzer calculated that lowering the temperature from 37 oC to 0 oC will slow 
down enzymatic processes 12 to 13 fold (Belzer & Southard, 1988).  
A number of studies have shown improved preservation at lower-than-body 
temperatures of solid organs (Belzer & Southard, 1988; Kasiske et al, 1990; 
Bonventre, 1992) and experimental free flaps (Donski et al, 1980; Gould et 
al, 1985).  
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With regards organ preservation by means of hypothermic storage, it is 
generally believed that the organ remains viable only for approximately 24 to 
48 hours. By decreasing the parenchymal cell’s metabolic activity and 
oxygen demand, hypothermia can retard the normal catabolic processes from 
causing damage to the ischaemic tissue . In a temperature range between 0 
and 4 oC Levy (1959) found the oxygen requirement of the canine kidney to 
be less than 5 % of normal. 
 
At body temperature, 50% survival time of rabbit muscle is 3,5 hours 
(Hickey et al, 1995) and 9 hours for skin flaps (May et al, 1978). Cooling to 
4 - 6 oC during ischaemia increases 50% survival time of skin to about 3 – 4 
days (Donski et al, 1980) and skeletal muscle to approximately 16 hours 
(Waugh et al, 2000). In studies on ischaemic rat muscle (cutaneous 
maximus), Li et al (1993) demonstrated that the muscle displayed normal 
viability without remarkable histologic abnormality after exposure of up to 6 
hours of normothermic ischaemia. After 10 hours at room temperature, 
profound injury was noted. Chachques et al (1985) reported similar findings. 
 
 Tsu-Min Tsai et al (1982) showed that hypothermic support of dog muscle 
flaps, particularly if preceded by initial flush with Collins solution, extended 
viability up to 96 hours.  
 
Yet hypothermia can itself be injurious to basic cellular function by 
depressing the parenchymal-cell ATPase activity, resulting in the 
inactivation of the sodium-potassium membrane "pump" and subsequent 
cellular swelling and metabolic imbalance (Belzer et al 1978). 
 
Potential complications exist as well with tissue perfusion. Although 
generally accepted that a hypertonic intracellular solution such as Collins 
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will prolong the ischaemic tolerance of tissues in both experimental and 
clinical settings, the perfusate, if too hyperosmolar or if administered 
under excessive pressure, can lead to the development of interstitial oedema 
and more pronounced tissue anoxia (Flores et al, 1972; Hicks et al, 1980).   
 
The factors involved in hypothermic damage (i.e. cold storage without 
perfusion) remains unknown, although this is a subject of extensive review 
(Bonventre & Weinberg, 1992; Bresticker et al, 1992).  
During cold storage, structural alterations in cell membranes occur and are 
characterised by a phase change of the membrane phospholipids from a fluid 
state to a more crystalline state (Bonventre & Weinberg, 1992; Southard & 
Belzer, 1993; D’Alessandro et al, 1994; Fuller, 1991). The rate at which this 
phase change occurs is not known, but equilibration of the tissue with the 
ambient temperature is quite rapid. The phase transition appears to be fully 
reversible for organs cooled for 10 or less hours and function post-
transplantation is rapidly regained (Bonventre & Weinberg, 1992; Clavien et 
al, 1992). 
 
It is generally believed that 4 phenomena contribute to hypothermic injury: 
1. Loss of energy-generating capabilities following mitochondrial damage may 
play a role. Simple cold storage results in loss of energy-generating abilities 
as a result of mitochondrial damage or the loss of precursors for ATP 
generation. If tissues cannot restore energy homeostasis, irreversible cellular 
injury results. 
2. Accumulation of toxic free radicals may also be involved in preservation 
injury (Hoshino et al, 1988; Risby et al, 1994).  
3. The effects of toxic free radicals and reperfusion injury / “ no-reflow”  in 
cold- stored tissues and organs have been implicated in preservation injury 
(Hoshino et al, 1988; Risby et al, 1994). Suppression of toxic radical 
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generation and various free radical scavengers by pharmacological means, 
have had some success in improving clinical tissue  and organ preservation 
(Douglas et al, 1987; Fuller et al, 1988; Winchell & Halasz, 1989; Pang, 
1990; Knight et al, 1991). 
4.   Other proposed mechanisms include activation of lysosomal catabolic 
enzymes, proteases and phospholipases (Pavlock et al, 1984; McAnulty et al, 
1991; Nicols et al, 1994). Active metabolites from arachidonic acids 
(thromboxane, leukotrienes) have also been implicated in reperfusion injury 
of preserved organs (Keppler et al, 1985; Post et al, 1993). 
 
Hypothermia has also been shown to result in cell swelling and thus organ 
dysfunction. Current cryopreservative solutions therefore contain additives 
designed to suppress hypothermically induced swelling  (Southard & Belzer, 
1993). Despite these additives, considerable damage occurs during storage at 
4 oC without continuous perfusion (i.e. cold ischaemia or simple cold 
storage). The addition of perfusion, although controversial in some studies, 
attempts to create a more physiological milieu in which the nutrients can 
reach the microcirculation. 
 
In summary, it is well-known that hypothermic storage of organs and tissues 
offers unquestionable improvement in survival. Prolonged cooling (without 
perfusion) results in cellular damage. The use of preservative solutions are 
designed not only to provide some homeostatic environment, but also to 
reduce hypothermic damage. The delivery of the cooled preservative solution 
by either simple flush or pulsatile perfusion is an area of debate, but the 
latter delivery technique may have advantages.  
This study will also aim to confirm the above proposals. Muscle flaps will be 
harvested and stored and a comparison made regarding quantitative muscle 
survival at normothermic (25 oC) versus hypothermic  conditions (4 oC). The 
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potential benefits of cold perfusion will be explored and compared to the 
effects of simple cold storage without perfusion. In each case regardless, 
hypothermic conditions will be carefully controlled to 4 oC and perfusion 
pressures will be maintained at similar mean arterial blood pressures as exist 
in normal rabbit physiology (refer Chapter 2 -  “MATERIALS AND 
METHODS”).  
 
1.4.3. Role of Free Radical Scavengers  
 
Following an ischaemic-reperfusion injury and the ensuing  free radical 
cascade (Figure 1), it can be seen that the superoxide radical and its 
derivative the hydroxyl anion, are capable of producing extensive cellular 
and subcellular damage.  It would follow that the addition of so-called “ free 
radical scavengers”  should minimise these pathophysiological changes and 
result in improved survival of the reperfused tissue or organ. 
The prevention of the action of free radicals produced by all the pathways 
would be more effective in preventing tissue damage than by blocking those 
produced by a single pathway. By inhibiting xanthine oxidase (Figure 1), 
allopurinol has been used to reduce superoxide production (Im et al, 1984; 
Angel et al, 1987; Suzuki et al, 1991; Suarez Nieto et al, 1992).  
Superoxide dismutase (SOD) and catalase has also been used to scavenge 
superoxide and hydroxyl radicals in the rat (Crikit et al, 1984; Sagi et al, 
1986; Smith et al, 1990).  
The iron chelator and free radical scavenger, desferrioxamine has also shown 
to improve skin flap survival (Sinaceur et al, 1984; Angel et al, 1989; 
Kohout et al, 1995).  
Amongst other crucial ingredients, the perfusion solution used in this study,  
University of Wisconsin solution, contains the free radical scavengers 
allopurinol (1 mmol/L) and glutathione (3 mmol/L). 
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1.4.4. Manipulation of Flap Models: the Role of Perfusion and Additional 
Strategies Designed to Enhance Tissue Preservation  
 
Many pathophysiological mechanisms operate during the insults of 
ischaemia, tissue preservation and reperfusion.  Additional strategies have 
been postulated which may ameliorate these insults. These may involve 
improving the physiological milieu or providing pharmacological additive/s 
which may target specific derangement’s. Given that there is no single agent 
which can counteract all the pathophysiological changes, the best possibility 
at present is a mixture of pharmacological agents added to the perfusate. 
 
Most involve either perfusion washout before (and possibly after) the 
ischaemic insult (Chait et al, 1978; Sawhney, 1980; Gould et al, 1985; 
Rosen et al, 1985; Rosen et al, 1987) or intra-arterial (Sagi et al, 1986; 
Zimmerman et al, 1987) or systemic infusion of free radical scavengers 
before or concomitant with reflow (Manson et al, 1986). The latter has been 
discussed above. 
 
The literature shows a general trend towards washing out the 
microcirculation prior to the ischaemic (Kohout, 1995).  This has been 
achieved by using simple flushing or active perfusion techniques and helps 
by removing blood and its toxic metabolites from the perfused tissue or 
organ. However, the subject remains controversial. 
 
Harashina & Buncke (1975) concluded that, in experimental rat leg 
amputations and replantations, no perfusion gives better results than 
heparinised saline solution or an intracellular (Downes) solution. 
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Although they could offer no explanation for their unexpected findings, a 
possible reason is that perfusion pressures were undocumented and 
uncontrolled. This may lead to marked and deleterious cellular and inter-
cellular oedema.  
 
Chait et al (1978), perfused rabbit epigastric skin flaps with various solutions 
containing mannitol, high molecular weight dextran, prednisolone and 
heparin and concluded that none of the perfusates had a beneficial effect on 
skin flap survival.  
 
Similarly, Gould et al (1985), concluded that early perfusion with Ross' 
solution is detrimental to the ultimate fate of the cold ischaemic flap, while 
late perfusion with the same solution offered no advantage over cold storage 
(6-7  oC) alone. 
 
In direct contrast to the above studies, Rosen et al (1985) increased flap 
tolerance to ischaemia by using a complex perfusate simulating rat plasma.  
The presumed aetiologic basis for this enhanced tissue survival is a delay in 
the onset of capillary and venular hyperpermeability in perfused flaps as 
compared to flaps in which stagnant blood remains. However, the 
complexity of the perfusate makes it difficult to assess which of the 
components are instrumental in ischaemia tolerance. 
 
Douglas et al (1989) perfused rat epigastric flaps with a simple Ringer 
lactate solution and showed a dramatic increase in flap tolerance to 
ischaemia.  
Hicks et al (1980) perfused 6 amputated rat hindquarter models with Ringers 
lactate, Collins hypertonic renal perfusate and dextran-dextrose 
(“ Perfudex” ). Their results indicated that Collins perfusate was less 
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damaging than Perfudex which, in turn, was less damaging than Ringers 
lactate. However, no comparison was made between perfusion with these 
solutions versus no perfusion at all.  
 
In a study using composite tissue, Gordon et al (1992) compared perfusion 
of amputated limbs with University of Wisconsin (UW) solution to topical 
cooling. Their results showed that pH and tissue levels of ATP declined three 
times more slowly in the perfused limbs. 
 
Kohout et al (1995) assessed the performance of several perfusion solutions 
on rabbit skin flaps in terms of flap viability and flap biochemistry. The 
solutions used were heparinised blood, UW and modified UW solution, 
Euro-Collins solution and a mixture of pharmacological agents targeting 
specific aspects of ischaemia / reperfusion injury. This mixture included 
phosphoenolpyruvate, desferrioxamine, nitrendipine, dextran 70 and a 
platelet-aggregating factor receptor antagonist.  
The viability of the skin flaps perfused with this mixture (81%) was 
significantly higher than that of any other of the groups (39% for controls, 
38% for Euro-Collins and 13% for UW solution). Biochemical performance 
of the skin flaps were also better when perfused with the mixture. 
 
 
Some of the more recognised (and sometimes controversial) manipulations 
are as follows: 
 
 
(a) Modification of pH: 
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Maintenance  of a “ normal”  or neutral pH has been considered optimal for 
preservation (Kallerhoff et al, 1985; Southard, 1990), yet a mild acidosis can 
be protective (Bonventre & Cheung, 1985). Given the proven beneficial 
effects in reducing the pH from 7,4 to 6,9 - 7,0 in kidney (Shanley et al, 
1988; Weinberg, 1985) and liver (Bonventre & Cheung, 1985), the question 
arises as to whether preservation would be improved by maintaining pH at 
6,9 - 7,0 during hypothermia. This may be of particular benefit in a 
metabolically active aerobic tissue such as muscle. In the case of organ 
preservation, maintaining pH in the lowered ranges mentioned above has 
also shown to improve the efficiency of the solution during normothermia 
(Ferwana et al, 1989; Currin et al,1991; Gao et al, 1991). Whether or not 
this may enhance the survival and efficiency of muscle post-replantation is 
not known, but raises interesting questions.  
 
Although the UWS used in this experimental study contains a phosphate 
buffer system, a lower pH value was found in the perfusate solution after 24 
hours (mean of 7,18). It remains possible that this mild acidosis has a role to 
play in enhancing survival in muscle as well as in those organs quoted in the 
above studies. 
 
(b) Desferrioxamine: 
 
 This has been shown to be a potent, non-selective scavenger of free radicals 
(Sinaceur et al, 1984). 
Also, by chelating iron, desferroxamine reduces the availability of this 
catalyst and hence the total load of free radicals in the reperfused tissues. 
This has been directly confirmed by measuring tissue levels of end-products 
of lipid peroxidation (Green et al, 1989). Again, the use of this 
pharmacologic agent is controversial.  
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Nishikawa et al (1991) suggested that desferroxamine had no effect on the 
reperfusion damage of vascular endothelium as seen on electron microscopy, 
microangiography and ultimate flap survival. Different animals, different 
drug dosages and different experimental protocols were used in each study. It 
may also be hypothesised that this inconsistency may be explained by 
different amounts of free radicals generated in each experimental scenario. 
 
Despite these inconsistencies, Kohout et al (1995) were convinced of the 
performance of desferroxamine and used it as a key agent in their 
pharmacologic mixture for cool perfusion of skin flaps. 
 
Furthermore, in  their study on secondary ischaemia due to venous 
obstruction in rat epigastric skin flaps, Angel et al (1989) found that 
desferrioxamine given prior to reperfusion improved flap survival. 
 
(c) Superoxide dismutase or catalase:  
 
Infusion of these agents just before perfusion of cold-preserved porcine 
kidneys improved renal function and morphology (Bosco & Schweizer, 
1988). Treatment of rabbit donor kidneys with indomethacin, to reduce 
cyclo-oxygenase mediated reactive oxygen species production prior to 
harvest, reduced lipid peroxidation products and tended to improve function 
after transplantation (Gower et al, 1989). The literature regarding the use of 
these agents in skin flaps, reports variable results (Pang, 1989). 
 
 
(d) Heparinised blood: 
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Cooley et al (1990), reported a significant improvement in survival of free 
flaps during ischaemic storage using perfusion with heparinised whole blood. 
 
Kohout et al (1995), perfused rabbit epigastric skin flaps with heparinised 
whole blood and showed increased flap viability compared to non-perfused 
controls, but this difference just failed to reach statistical significance.  
 
Both of these studies suggest that heparin can regulate, by a mechanism yet 
to be elucidated, the release of inflammatory mediators by blood cells and 
platelets retained in the microvasculature. Heparin may also have some 
influence on the hypoxic damage and cell swelling of the endothelial and 
parenchymal cells, which are other sources of inflammatory mediators. The 
use of heparin as an antiplatelet drug and its effects on antithrombin III is 
well established. 
  
Rosen et al (1985), used a synthetic plasma substitute and pointed to the 
possibility of improved results with whole blood washout being independent 
of its cellular component. They suggest that perfusion washout improves the 
ischaemic tolerance and prevents the “ no-reflow phenomenon in rat 
epigastric skin flaps. The postulated mechanism is due to the prevention of 
capillary endothelial damage secondary to the presence of formed blood cells 
or their products of haemolysis. They also speculated that washout may also 
prevent sludge formation and therefore thrombus. Intuitively, the benefits of 
the “ acellular”  components of blood seem to be a reasonable conclusion,  as 
plasma is a complex solution of ions, macromolecules and buffers (Kohout et 
al, 1995).  
The role of the cellular component of blood (i.e. red and white blood cells 
and platelets), is controversial. It is likely that red cell rigidity and sludging, 
  
23 
 
23 
polymorph margination and degranulation and platelet aggregation, outweigh 
their potential benefits. 
  
Oxygenated plasma  pumped on a continuous basis has been found to be 
effective in preserving the kidney for more than 24 hours (Belzer et al, 1967; 
Belzer,1973;  Magnussen et al,1976).This expensive and complex means of 
preserving organs has worked clinically over the past two decades because 
plasma with dissolved oxygen is extremely physiological. A solution that is 
anything but physiological would best be used on a washout basis, rather 
than delivered in a pulsatile fashion.  
 
(e) Calcium channel blockers:  
 
There has been considerable interest regarding the role of calcium as a 
mediator of muscle necrosis during reperfusion (Katz & Reuter,1979; Poole-
Wilson et al, 1984; Walker, 1986).  
It has long been known that there is an accumulation of calcium associated 
with necrotic tissue but the question remains as to the potential role of 
intracellular accumulation of calcium in precipitating pathological changes in 
the cell.  
 
Calcium overload can occur during the ischaemic period because of a 
redistribution of tissue stores and cause damage (Poole-Wilson et al, 1984). 
However, the most significant calcium entry occurs when blood, laden with 
calcium, is reintroduced and the cellular membranes are vulnerable to 
calcium influx due to defects in the membrane itself or alterations in the 
membrane calcium channels (Crake & Poole-Wilson,1986).  
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Smith et al (1990), confirmed that total tissue calcium levels heralds the 
onset of catabolic cascades and are associated with significant necrosis in 
skeletal muscles.  
 
Improved survival was shown by decreasing extracellular calcium (using 
radical scavengers, controlled oxygen delivery and low ionised calcium 
concentrations).The early ability to extrude intracellular calcium from the 
reperfused cell was associated with significant salvage of muscle. This 
ability may be intimately associated with adequate intracellular energy 
levels, again confirming the importance of providing energy substrates in the 
perfusate. 
 
It would therefore seem appropriate that any perfusion solution used should 
attempt to decrease intracellular calcium levels and, at the same time, ensure 
an adequate supply of energy.  
Calcium channel blockers have been shown to be protective against the 
effects of ischaemia in certain circumstances in organ (Elkadi et al, 1989; 
Currin et al, 1991) and in tissue models (Stein et al, 1989).  
 
Stein et al (1989) showed that pre-treatment of rodent skin flaps with the 
calcium channel blocker, verapamil, markedly improved ischaemic survival. 
These effects were mediated by verapamil’s ability to protect against oxygen 
free radicals. Calcium channel blockers also have an important vasodilatory 
function (Malis et al, 1983).  
 
Using Carolina rinse solution, which contains a calcium channel blocker, 
Currin et al (1991) were able to prolong cell viability compared to University 
of Wisconsin solution. 
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(f) Prostanoid modifiers:  
 
 Much of the reperfusion injury and the “ no-reflow “  phenomenon (Chait et 
al, 1978) can be attributed to endothelial cell damage caused by accumulated 
free radicals. Endothelial damage exposes the subendothelial collagen and 
provides thrombogenic sites where platelets aggregate and give rise to large 
increases in plasma levels of thromboxane (TXA2).  
 
Thromboxane has a direct vasoconstrictor effect. Prostacyclin (PGI2) is a 
vasodilatory arachidonic acid metabolite which, in non-ischaemic tissues, is 
known to increase blood flow in both major vessels and the microcirculation 
(Higgs et al, 1979), including that of skin flaps (Knight et al, 1985). PGI2 
also inhibits platelet aggregation and at higher concentrations, platelet 
adhesion and platelet thromboxane release (Knight et al, 1991). 
Knight et al (1991) demonstrated improved ischaemic skin flap survival in 
the rabbit with pre-treatment of prostacyclin and prostanoid modifiers such 
as dipyridamole. This was attributed to the vasodilatory and antithrombotic 
properties of these drugs.  
 
 
(g) Other agents: 
 
Anti-PAF – Platelet activating factor  (PAF) is thought to be important in the 
pathogenesis of the reperfusion injury. PAF is thought to affect this injury 
through its action on neutrophil and platelet activation (Heuer et al, 1990). 
WEB 2170 is a platelet-activating factor antagonist which may reduce 
migration of neutrophils and decrease levels of thromboxane (Kohout et al, 
1995). 
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Macromolecules -  The inclusion of macromolecules such as mannitol or 
hydroxyethyl starch in UWS  and in some studies, Dextran (Marshall et al, 
1991; Kohout et al, 1995), helps prevent post-perfusion increase in tissue 
water, probably through their osmotic action across cell membranes. These 
effects may only be temporary and, after a time, increased tissue water may 
be found. Kohout et al (1995) reported on “ rebound oedema”  in flaps 
perfused with solutions containing macromolecules. 
These effects may be due to local metabolites and disruption of cellular ion 
exchange mechanisms subsequent to the washout of free radical scavengers 
and osmotically active macromolecules. 
Dextran, in addition to its oncotic effects,  has rheological properties and 
decrease Rouleaux formation of red cells and therefore improves flow in the 
microcirculation.  
 
Purine Supplementation and Glutathione – the benefits of added adenosine 
and glutathione will be discussed (refer section 1.4.6.)  
 
Cyclosporin A – the role of the cellular components of blood, particularly 
neutrophils and platelets, is a very complex one and beyond the scope of this 
study. It is therefore not discussed in any great detail here.  
Suffice it to say that methods which affect neutrophil chemotaxis, migration 
and degranulation are likely to result in further improvements in flap 
survival.  
 
The use of agents which block these processes have been investigated and 
Kucukcelebi & Ozcan (1992), report that cyclosporin A (CsA) offers 
significant advantages in increasing perfusion flap viability. CsA has 
multiple actions, including producing a general decrease in leukocyte 
responsiveness. 
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CsA also inhibits synthesis and action of many inflammatory mediators, such 
as cytokines. It may thus block the amplification mechanisms inherent in the 
inflammatory response. 
 
Haemoglobin solutions – some investigators have reported on the use of 
perfusion of amputated limbs using synthetic haemoglobin solutions viz. 
fluorocarbon solutions (“ Perfudix” ). 
Usui et al (1985), found that continuous gravity perfusion with a 
fluorocarbon solution was more effective in the prevention of systemic 
acidosis associated with reperfusion than either intermittent perfusion or 
topical cooling. 
 
Pharmacologic Mixtures –the pathways involved in the ischaemia /storage / 
reperfusion injury are extremely complex in nature. It is therefore very likely 
that a pharmacological mixture or “ cocktail”  comprising individual 
components which target separate mechanisms in these injury processes, will 
have the greatest efficacy. In fact, all modern preservation solutions 
comprise mixtures of various solutes, solvents and pharmacologic agents, 
differing in their nature or quantity.  
 
Kohout et al (1995) showed an 81% survival of rabbit skin flaps perfused 
with a pharmacological mixture compared to 39% survival in non-perfused 
controls. The mixture they used consisted of heparinised blood, mixed with 
phosphoenolpyruvate, the  calcium channel blocker nitrendipine, 
desferroxamine, WEB 2170 and Dextran 70.  
Other sporadic reports, mainly in the field of organ transplantation, have 
shown some survival benefits with the use of other agents, such as protease 
inhibitors, phenothiazines, atrial natriuretic peptide and polyethylene glycol 
(Bonventre & Weinberg, 1992). 
  
28 
 
28 
The literature abounds with vast numbers of agents that have been tried on 
various organ and tissue models and this, in itself, is testimony to the fact 
that there is no single agent which has undisputed benefits in all cases. With 
further insight into the pathophysiology involved with ischaemia / storage / 
reperfusion scenarios, we can expect future literature to document a plethora 
of agents and concoctions all aimed at manipulating these events. 
 
(h) Ischaemic Preconditioning: 
 
Ischaemic preconditioning, defined as brief episodes of ischaemia and 
reperfusion, has been thought to offer some protection from reperfusion 
injury that follows prolonged ischaemia. The protection has been described 
as having 2 windows of opportunity: a transient acute phase lasting 
approximately 3 hours (Parratt, 1994; Lee & Linweaweaver, 1996) and a 
delayed second window which begins after several hours and can last for 
more than 24 hours ((Parratt, 1994; Yellon et al, 1998). 
 
In cardiac muscle, following a primary stress such as ischaemic 
preconditioning, has frequently been associated with protection from 
ischaemia-reperfusion (I-R) injury (Currie et al, 1993; Tanake et al, 1998). 
This is shown by the expression of heat shock protein 70 (Hsp 70) in the 
delayed phase. In skeletal muscles, studies of delayed protection by this 
method are not as common. Although improved perfusion of capillaries has 
been reported after prolonged ischaemia followed by short-term reperfusion 
in rat hind limbs (Pudupakkam et al, 1998), a long-term reperfusion study in 
the rat latissimus dorsi, showed only a marginal decrease in muscle necrosis 
(Carroll et al, 1997). 
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In order to further delineate this question, Lepore & Morrison (2000) 
investigated the ability of ischaemic preconditioning to induce expression of 
Hsp 70 and also to improve muscle survival after ischaemia-reperfusion 
injury using the rat gastrocnemius muscle. They concluded that 
preconditioning (in this case by means of tourniquet induced ischaemia) did 
not produce delayed protection from ischaemia-reperfusion injury. 
 
The available literature to date does not provide sufficient evidence to 
support this modality of treatment as having a delayed protective effect 
against skeletal muscle necrosis after I-R injury, at least in clinical practice.  
 
1.4.5. Continuous vs. Pulsatile Perfusion 
 
Theoretically, continuous organ (and possibly tissue) perfusion would be the 
most effective method of maintaining intra- and extra-cellular homeostasis, 
providing the solution was physiologic (Hicks et al, 1980). In the field of 
preservation and transplantation, studies tend to show that pulsatile perfusion 
produces superior results, particularly for prolonged storage. However, it 
must be borne in mind that other centres commonly employ flush topical 
cooling (a single flush of the organ’s vasculature with a preservation 
solution, usually UWS, followed by topical cooling). This  intercellular 
"washout" solution is effective in avoiding endothelial injury and oedema, 
while removing metabolites and intravascular elements and creating an 
environment for the cell to continue its metabolism (Belzer,1973 ; Halasz et 
al,1976 ; Magnussen et al,1976).  
 
The field of tissue preservation, specifically limb and flap preservation, is an 
entirely different arena from organ preservation.  
 
  
30 
 
30 
Although the end result of ischaemia is the same for all cells, different 
organs and tissues have different metabolic profiles and ischaemic 
tolerances. The early data on tissue preservation was indeed conflicting. 
Regardless of which method of perfusion or flushing is chosen,  most studies 
show that beneficial effects are generally obtained using physiologic colloid 
containing solutions. 
 
Whilst perfusion may well be more physiological (flow in the 
microcirculation is, at least, oscillatory), early studies suggested that it may 
in fact, be harmful. Hicks (1980), perfused rat hindlimbs by means of an 
intermittent perfusion pump (pressure un-stated)  and abandoned this in 
favour of continuous perfusion, due to the gross oedema that resulted. 
More recent studies of skin flap and amputated limbs (composite tissues) 
have generally shown improved results with perfusion. Kohout et al (1995) 
showed good results on skin flaps using machine perfusion with a peristaltic 
pump. In their study, careful attention was paid to maintaining intraluminal 
pressure below 150 mmHg. Similarly, Gordon et al (1992) showed improved 
results with pulsatile perfusion on composite tissues. The particular 
perfusion delivery technique (continuous versus pulsatile) appears to be of 
great importance, certainly in the tissue models, such as skin flaps and 
amputated limbs. 
 
Although flap perfusion offers attractive theoretical survival benefits, there is 
still lack of agreement on whether the vascular bed of the replanted or 
transplanted tissue should be perfused by active mechanical pumping or 
"washed out" by simple flushing. It would seem rational to deliver the 
perfusate by the most physiological means. This may be especially important 
in a highly vascular structure such as muscle, where flow in the 
microcirculation is intermittent, albeit oscillatory, rather than continuous. 
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Controlled intermittent pulsatile delivery, as used in this study, seems the 
most logical choice, yet this parameter warrants further investigation. 
 
1.4.6. The Perfusate 
 
The simple exposition of Starlings law is that blood circulation through a 
capillary bed loses fluid to the interstitial space when the hydrostatic 
pressure within the capillary exceeds the sum of the external tissue pressure 
and the colloid osmotic pressure within the lumen of the vessel. In perfusion 
experiments, the artificial medium and perfusion pressure should be selected 
to achieve a similar balance, so that net fluid loss from the vascular 
compartment and cellular and interstitial oedema does not occur. Since 
perfusion pressure can be controlled, it is the composition of the artificial 
medium or perfusate that is of vital importance in maintaining homeostasis, 
preserving organ and tissue function and minimising ischaemia / reperfusion 
injury.  
 
In an attempt to find an "ideal" perfusate solution that could be used in this 
study, a review of the literature showed that most work in this field was 
performed on organ preservation. With developing expertise, however, it 
has become clear that different tissues have different metabolic requirements 
and ischaemic profiles and that solutions of different compositions are 
required for different tissues (Belzer & Southard, 1988). A solution suitable 
for hepatocyte preservation may quite different from that required by kidney, 
skin or muscle. 
 
Collins et al (1969), described a solution (Table 1) that they used 
successfully to preserve dog kidneys on ice for up to 30 hours. This solution 
was high in [K+] and [Mg2+]; it included glucose, heparin, procaine and 
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phenoxybenzamine and was phosphate buffered to a pH of 7,0 at 25oC. The 
kidneys were flushed with 100 –150 ml of this ice cold (0 - 4oC) solution and 
remained on iced saline for the remainder of the storage time. It was quickly 
found that heparin (although this is controversial), procaine and 
phenoxybenzamine were unnecessary and that the latter could be toxic. The 
rationale for the salt composition of the solution was that it mimicked 
intracellular fluid, although the [Mg2+] is considerably higher.  
 
The glucose and the impermeant anion, SO42- in this solution may have been 
the primary reason for the success achieved with renal preservation, as these 
2 substances limit fluid uptake and therefore suppress cell swelling (Green & 
Pegg, 1979).  
 
The high [K+], if present only with a highly permeable anion such as Cl-, 
may potentiate cell swelling associated with depletion of energy stores. This 
is because the ATPase pump is designed to export Na+ and not K+ from the 
cell. Therefore, solutions high in potassium may in fact be suboptimally 
protective or even toxic at normothermia (Von Oppell et al, 1990). For this 
reason, high [K+] preservation solutions potentially pose some risk if 
maximal cooling is not maintained throughout preservation. On the other 
hand, high [K+] solutions have several theoretical advantages that may 
account for the extensive practical success with them. “ Preservation of 
intracellular composition”  is a frequently cited rationale for using high [K+]   
levels, but the actual beneficial mechanisms are more complex (Bonventre & 
Weinberg, 1992). Maintaining cell K+ during preservation avoids the work 
load required to pump out accumulated Na+ during the initial stage of 
reimplantation, at a time when the metabolic status of the cell may be 
particularly precarious (Brezis et al, 1984).  
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Furthermore, high [K+] maintains a slightly acidic intracellular pH that 
appears to be most favourable for resistance to injury (Bonventre & Cheung, 
1985; see Section 1.4.4 (a)). 
 
The inclusion of high [MgSO4 ] in Collins solution was another controversial 
additive and its beneficial effects were doubtful.  
When the Eurotransplant Organisation agreed on a standardised preservation 
solution in 1976, it chose a modified Collins solution that omitted MgSO4 
but had a higher concentration of dextrose and total osmolarity (see Table 
1). This solution was named Euro-Collins and has been widely used for 
simple flush preservation (Squifflet et al, 1981). The literature, therefore, has 
shown several solutions to have been successful for solid organ preservation 
with Collins and Euro-Collins solutions  being especially successful in 
preserving kidneys (Moukarzel et al, 1990; Bonventre, 1992).  
 
Many other investigators attempted to improve on these preservation 
solutions, but none conferred any practical advantages over Collins, Euro-
Collins (and more recently Belzer) solutions. Although these solutions were 
satisfactory for the kidney, none were particularly good for preservation of 
other organs. 
 
With the advent of cyclosporine in the 1980’s, successful transplantation of 
other organs necessitated the development of preservative solutions that 
could be used for all organs. This was accomplished in the late 1980’s by the 
Belzer and Southard group at the University of Wisconsin. This has become 
the standard cold storage preservative for most organs and there has been 
growing evidence that is superior to other solutions (e.g. Euro-Collins), in 
terms of preservation times and quality (Belzer,1988; Buhren et al, 1991; 
Ferguson et al, 1991).  
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Belzer UW solution (ViaSpan, DuPont Merck Pharmaceuticals, 
Wilmington, Delaware 19880) contains crucial ingredients thought to be 
essential for an effective cold storage solution (Southard et al, 1990).  
“ UWS”  attracted wide interest as it was designed to address many of the 
major patho-physiologic events thought to contribute to both cold and warm 
ischaemic injury (Belzer & Southard, 1988). 
It has been successfully  used in preservation of a variety of organs, such as 
kidneys (Ploeg et al, 1988), heart (Swanson et al, 1988) and liver (Jamieson 
et al, 1988). Of more interest to the reconstructive surgeon, it has been used 
with good results in skin flaps (Turk et al, 1991) and in composite tissue 
models (Gordon, 1992).  
 
The success of University of Wisconsin Solution (UWS) it attributable to 
the simulation of a highly favourable micro-environment for (normal) and 
ischaemic cells and to certain substrates and additives which limit ischaemic 
and reperfusion damage. These components (refer Table 1), which enhance 
its preservation performance include: 
1. Colloids such as raffinose and lactobionic acid which act as osmotically 
active, non-metabolisable impermeants to suppress hypothermic cell 
swelling. This may be advantageous in preventing oedema of a perfused 
tissue, such as a muscle flap (Belzer,1973 ; Drummond & Shiel,1974 ; 
Halasz et al,1976). 
2. Pentafraction or hydroxyethyl starch (HES), a modified pentastarch, 
provides sufficient colloid osmotic pressure to prevent expansion of the 
interstitial space either during organ flush or perfusion. Marshall et al 
(1991) modified this component and reported success by replacement of 
HES with Dextran 40. In addition to its importance as a colloid, dextran has 
rheological properties and may improve flow in the microcirculation. 
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3. Glutathione and allopurinol (free radical scavengers), to prevent cytotoxic 
injury from free radicals. 
  4. Potassium phosphate for effective hydrogen ion buffering to prevent 
intracellular acidosis. The high potassium level may also be advantageous in 
conserving energy by preventing muscle from contracting, akin to induced 
asystole of cardiac muscle during open heart procedures 
5. Adenosine for regenerating high energy phosphate compounds, important in 
reperfusion and may play an important role as high energy substrates 
necessary for subsequent muscle function.  
 
Furthermore, UW solution like the original Collins solution contains a high 
concentration of potassium, which is thought to suppress efflux of potassium 
from cold stored cells and thus conserve energy needed on reperfusion to 
restore potassium in the cell. 
Belzer UW cold storage solution (UW-CSS) has an approximate calculated 
osmolarity of 320 mOsM and a pH of 7,4 at 25 OC. 
 
The development of this solution has, in many studies, clarified some 
rudimentary concepts about organ and tissue preservation. The first is that 
hypothermia is a key factor as it retards the rate of tissue metabolism and 
therefore degradation. The second is that the physical environment of organs 
or the tissue created by the components should be as physiological as 
possible. Appropriate additives such as colloids help suppress hypothermia-
induced cellular swelling. Thirdly, certain biochemical agents help the cell to 
restore normal metabolism when reperfused, such as glutathione and 
allopurinol, which are involved in scavenging free radicals (refer Section 
1.4.1). 
 
  
36 
 
36 
Two of these pharmacological additives have been thought to make a definite 
difference (Southard et al, 1990; Biguzas et al, 1990) and warrant further 
discussion. 
  
Adenosine is added to provide purine substrate for resynthesis of ATP. 
Adenosine is initially converted to AMP by adenosine kinase (AK), an ATP-
requiring enzyme. Since AK shows substrate-dependent inhibition, low 
concentrations of adenosine are more efficiently metabolised. 
It is becoming increasingly appreciated that both ATP and adenosine activate 
multiple signalling mechanisms. This occurs via cell surface receptors in 
both tubular and vascular cells, so that effects on haemodynamics and cell 
work loads, as well as effects on repair processes, may play a role in 
protection provided by purine supplementation (Paller et al, 1990).  
In a study of liver preservation, adenosine was the only clearly beneficial 
pharmacological additive to UWS for cold storage (Marshall et al, 1990). 
Adenosine, which regenerates ATP, also contributes towards energy 
homeostasis and may be very important for muscle metabolism and energy 
repletion following ischaemia. Indeed, Vary et al (1979) have suggested that 
depletion of adenosine is responsible for the inadequate energy supply for 
the metabolic processes in the cell and that it preceded mitochondrial 
damage as the indicator of cell death. 
 
Glutathione is depleted during both cold and warm ischaemia. It is felt that 
reduced glutathione (GSH) or one of its component amino acids, glycine, are 
protective against lytic cell damage occurring during ischaemia i.e. provide a 
degree of membrane stabilisation. In addition to these direct cytoprotective 
effects, GSH or glycine may enhance endothelial cell activity (Bonventre & 
Weinberg, 1992).  
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In one study however, a UW variant containing adenosine but not 
glutathione provided as much protection as the complete formulation, which 
suggests that glutathione was not necessary (Marshall et al, 1990). 
 
The remaining components of the original UWS, insulin, dexamethasone and 
penicillin, do not appear to be necessary for  preservation of kidney or liver 
and, presumably other tissues (Biguzas et al, 1990). 
 
As generally true for studies on tissue preservation, successful clinical 
application has outpaced study of all mechanistic issues, but sufficient data is 
available to draw reasonable conclusions about the components responsible 
for the success of UWS. It is not only a theoretical choice for a perfusion 
study but has been shown in previous work to be of benefit. 
 
Angel et al (1993) showed improved skin flap survival following pre-
ischaemic perfusion with UWS at room temperature. Although Gordon et al 
(1992) showed beneficial effects of UWS by perfusing composite tissue. Its 
use in muscle flaps has been discussed in Sections 1.4.2 and 1.4.4. 
 
An analysis of this data suggested that this solution may be the “ best”  
currently available “ off-the-shelf”  preservation solution. UWS was therefore 
considered as the solution of choice for the muscle flap model used in this 
current study.  
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Table 1: Composition of preservation solutions 
   COMPOSITION 
 
 
COLLINS * 
 
EURO- 
COLLINS**  
   UWS *** 
COLLOIDS (g/l) 
hydroxyethyl starch 
 
   
50 
FINAL 
ELECTROLYTE 
CONCENTRATION 
(mmol/l) 
potassium 
sodium 
chloride 
calcium 
magnesium 
 
 
 
 
115 
10 
15 
30 
30 
 
 
 
115 
10 
15 
 
 
 
 
 
 
 
125 
30 
 
5 
5 
IMPERMEANTS 
      (mmol/l) 
lactobionate 
raffinose 
osmolality (mOsm/l) 
 
 
 
 
 
320 
 
 
 
 
355 
 
 
100 
30 
320 
BUFFER 
KH2PO4 [HPO4] 
HCO3- 
pH (at 25oC) 
 
 
57,5 
10 
7,0 – 7,3 
 
57,5 
10 
7,0 – 7,3 
 
25 
 
7,4 
OXYGEN-FREE 
RADICAL 
SCAVENGERS (mmol/l) 
glutathione 
allopurinol 
 
 
 
 
 
  
 
 
3 
1 
ENERGY 
SUBSTRATES (mmol/l) 
adenosine 
glucose 
 
 
 
 
126 
 
 
 
194 
 
 
5 
 
 
ADDITIVES 
insulin (u/l) 
dexamethsone (g/l) 
penicillin (u/l) 
 
 
 
  
      40 
       8 
   200 000 
* - from Collins, 1969; ** - from Johnson, 1983; *** - from Southard et al, 1990 
1.4.7. Quantification of Skeletal Muscle Necrosis – a Grading System of 
Ischaemia 
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A review of the current literature has shown mixed and conflicting data 
regarding perfusion of experimental flap models. Results have been mixed, 
partly due to differences in flap model, animals tested, temperature of 
ischaemic storage, method of perfusion and type of perfusate.  
 
Other important reasons for such incomparability of results may be 
incomparable experimental models and a lack of a uniform grading system of 
ischaemia. A review of the literature has shown that very few accurate 
quantification methods of muscle necrosis exist.  
Chachques et al (1985) described the quantification of muscle ischaemia 
based on the histochemical enzyme stain, nitroblue tetrazolium (NBT), 
which stains viable muscle.  
Labbe et al (1988) further describe techniques of quantifying post-ischaemic 
muscle necrosis based on the nitroblue tetrazolium (NBT) and  99mtechnetium 
pyrophosphate staining of viable muscle. The NBT test has been used in 
other muscle studies (Hickey et al, 1992; Waugh et al, 2000).  
 
Although popular, the NBT test has certain inherent problems. This test 
relies on reduction of tetrazolium salts by NAD/H, NADP/H, cytochromes or 
flavoproteins through the action of tissue diaphorase or dehydrogenase 
enzymes. Absent staining occurs when these enzymes become inactive 
following cell death. Areas of staining were either traced out freehand 
(Morris et al,1993) or subjected to computerised planimetry (Blebea et 
al,1987).  
False positive nitroblue staining can occur if adequate reperfusion does not 
take place (Factor et al, 1981).  
Calcium-mediated reperfusion injury destroys dehydrogenase activity and 
washes out free dehydrogenase from living cells. False negative staining 
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could occur if living myocytes have active dehydrogenase but depleted 
substrates (NAD, NADP) (Labbe et al, 1988). These events may be 
particularly applicable in this current experimental model as an ex-vivo 
situation exists without reperfusion of circulating blood and where the 
effects of perfusion – reperfusion of a preservation solution are in question. 
Although this technique is relatively simple and inexpensive, we felt that 
there are inherent inaccuracies as only a gross appreciation of ischaemic 
damage is obtained, which demonstrates established ischaemia or cell 
necrosis. The critical ultrastructural features of early ischaemia are, of 
course, not demonstrated.  
 
We have investigated quantitative enzyme histochemistry using a variety of 
propriety enzyme systems and have abandoned these techniques in favour of 
the more accurate combined light and electron microscopic features 
described below. In our hands, enzyme histochemistry had inherent problems 
of variable staining of type 1 and 2 muscle fibres (even in normal muscle), 
difficulties in quantifying early mitochondrial changes and inaccuracies even 
with computer analysis of varying reflectance patterns.    
 
Light microscopy  has long been used in studying the effects of ischaemic 
on skeletal muscle. Clarke (1946), applied tourniquets to the legs of rabbits 
and rats and documented the corresponding histologic findings with time. 
After only 2 hours of ischaemia, the transverse striations of many fibres were 
accentuated and after 4 hours, some fibres were beginning to fracture into 
discs at the Z line, with preservation of striation. 
  
Later changes showed reduced stainability of Q and Z bands with 
progressive loss of the banding pattern or cross striations, which was reduced 
in proportion to the disorder of chemistry. Waxy or hyaline change 
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represented a further, delayed breakdown of the fundamental architecture of 
the myofibrils. Evidence suggests that granular change, in the absence of 
waxy or hyaline degeneration, may characterise milder and reversible 
degrees of damage. If, in the course of the disease process, the ischaemia is 
progressive with massive necrosis, there is a period when the destroyed 
fibres have not yet been exposed to autolysis and phagocytosis. This process 
is known as Zenker's hyaline degeneration, seen as a homogeneous, 
structureless, faintly acidophilic change in the sarcoplasm. The muscle nuclei 
appear pyknotic and the striations disappear. Death of the muscle fibre is not 
established until structural collapse occurs. These changes, indicative of 
progressive ischaemia, are well described and accepted as histopathologic 
criteria of ischaemic damage. 
 
In their study, Gordon et al (1992) evaluated muscle ischaemia based on 
similar features reported by Harman (1947). This system is one of the few 
quantitative light microscopic grading systems. It includes cross striations, 
non-homogeneous eosinophilic staining of the cytoplasm and alteration of 
the nuclear-to-cytoplasm ratio. 
  
We have modified this system and have included a broader spectrum of 
cytoplasmic changes. Furthermore, we have abandoned nuclear-to-
cytoplasmic ratios, as even under high power, we feel it is impossible to 
accurately measure this relationship. We therefore include nuclear pyknosis 
as features of nuclear damage, as this is easy to perform and correlates with 
the degree of progressive nuclear insult. 
Using light microscopic criteria on ischaemic porcine muscle, Morris et al 
(1993) documented swollen nuclei, separation of myocytes by intercellular 
oedema, myofibrillar disruption and occasional fragmentation. These 
changes were only reported qualitatively and no precise grading system 
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mentioned. Furthermore, we feel that these changes are extremely difficult to 
accurately assess on light microscopy and we reserve these features for 
quantitative electron microscopic evaluation. 
 
Ultrastructural changes of ischaemic damage represents the "gold-
standard" and allows both quantification of the degree of change and 
detection of early features of ischaemic damage before an irreversible 
situation is reached. 
 
Gregory & Mars (1992) assessed sequential morphological changes on an 
ultrastructural level after an ischaemic insult. They reported glycogen loss, 
intermyofibrillar oedema, mitochondrial damage and myofibrillar 
disorganisation. These changes were documented only as a qualitative 
assessment, without applying strict quantitative criteria. 
  
On the other hand, Morris et al (1993) used the EM grading system as 
proposed by Ashford Gatley & Wilson (1988). Grading of ischaemia was 
either reported as grade 1 (normal) through to grade 4 (lethal).  
 
This system represents one of the few quantitative EM grading systems. 
However, this system is entirely based on EM changes in cardiac muscle 
which has several distinct ultrastructural differences (e.g. intercalated discs) 
as compared with skeletal muscle. Although a reasonable extrapolation to 
skeletal muscle can be made, inherent differences do exist.  
Furthermore, this grading system does not specifically count and quantify 
each ultrastructural change as occurs at each grade of injury.  
 
We have therefore proposed a new ischaemic grading system based on 10 
overall parameters -  a combination of 3 histopathologic and 7 ultrastructural 
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features of ischaemic damage. These features are well accepted criteria of 
varying degrees of ischaemic insult, which have been extensively used in 
many experimental models. We believe that our system offers certain 
important advances.  
 
Firstly, by combining light and electron microscopic changes, a more 
complete assessment of the effects of ischaemia is achieved. The electron 
microscopic features are therefore weighted as these changes are more 
important than light microscopic changes. This system offers a quantitative 
analysis applicable specifically to skeletal muscle, which is easily 
reproducible, simple and comprehensive.  
Furthermore, it offers the opportunity for assessing early, potentially 
reversible ischaemic damage.  
The grading system  of skeletal muscle ischaemia is described in detail in 
CHAPTER 2 - MATERIALS AND METHODS. 
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CHAPTER 2 -  MATERIALS AND METHODS 
 
2.1. ANIMAL MODEL AND SURGICAL PROTOCOL 
 
The rectus femoris muscle in the New Zealand White rabbit was used as the 
skeletal muscle flap model. A total of 10 flaps were raised using 5 healthy 
adult New Zealand White rabbits of mixed sexes. Weights ranged from 4,15 
kg to 5,0 kg with an average weight of 4,44 kg. 
 
All surgical procedures were carried out using aseptic techniques in the 
Central Animal Service operating theatres at the University of the 
Witwatersrand Medical School, Johannesburg, South Africa. Anaesthetic 
procedures and general care of the animals was conducted under the 
supervision of a qualified veterinarian. The study was approved by the 
University of the Witwatersrand Ethics Committee (refer Section 2.12.) 
 
The experimental animal was anaesthetised using 60 mg/kg ketamine 
(“ Ketalar”  - Parke Davis Pharmaceuticals) and  4 mg/kg zylazine HCl 
(“ Rompun”  2% - Bayer Pharmaceuticals). Anaesthesia was maintained for 
the duration of surgery using repeated bolus doses of these anaesthetic agents 
as necessary. The animal was placed in a suitable restraint and the limb to be 
operated on was shaved, cleaned and draped. Bilateral longitudinal incisions 
were made in the groins and dissection performed to expose the rectus 
femoris muscles, the femoral vessels and the vascular pedicle to the muscle. 
 
For each experimental animal, the rectus femoris muscle to be perfused 
(labelled “TEST MUSCLE”) was chosen randomly and the corresponding 
contralateral rectus femoris muscle served as the control (labelled 
“CONTROL MUSCLE” ). Each rabbit therefore served as its own control. 
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2.2. RADIOGRAPHIC STUDY 
 
A radiographic study was performed in order to study the vascular anatomy 
of the femoral artery and the branches to the rectus femoris muscle flap as 
seen on angiography.  
 
Two New Zealand White rabbits were used in this study. Using a similar 
anaesthetic technique and surgical protocol as above, the rectus femoris 
muscle flap was dissected and isolated on its vascular pedicle as an island 
flap. In the first animal (“ Rabbit 1” ), the femoral vessels were ligated (using 
stainless steel “ Liga”  clips) just proximal to the vascular pedicle of the rectus 
femoris muscle. In the second animal (“ Rabbit 2” ), only the pedicle to the 
muscle flap was ligated, with the femoral vessels remaining uninterrupted. 
 
A midline laparotomy was then performed in each animal and the aorta was 
identified and canulated. A distal aortagram was then performed by flushing 
with 25ml “ Conray”  contrast medium under screening control. X-ray films of 
the groin were then taken approximately 2-3 seconds later, to include the 
femoral vessels and the vascular pedicle of the muscle flap. The animal was 
then sacrificed with an intravenous bolus of sodium pentobarbitone (“ Eutha-
naze” , Centaur Laboratory) using a dosage of 100mg/kg.  
 
The angiographic findings are described in Chapter 3 – RESULTS, Section 
3.2. and are illustrated in Plates 3.2 A and B. 
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2.3. DISSECTION OF THE RECTUS FEMORIS MUSCLE FLAP AND 
ITS VASCULAR ANATOMY  
 
Via a longitudinal incision extending from the inguinal region in the groin to 
the knee, the rectus femoris muscle was identified and dissected free. 
Following division of its origin on the pelvic bone and its insertion into the 
patella, the muscle flap was mobilised as an island pedicle flap on its 
vascular pedicle. This part of the dissection was performed under 
magnification and included meticulous identification of the proximal and 
distal superficial femoral artery and veins and their respective branches and 
tributaries. This is described and illustrated in detail in Chapter 3 –
RESULTS, Section 3.1, Plates 3.1 A – C.  
 
2.4. MANIPULATION OF THE MUSCLE FLAP 
 
Prior to division of the proximal vessels, the femoral artery was canulated 
(see Plate 2.4) and baseline recordings of the mean systemic arterial 
pressures was obtained using a pressure transducer (“ Stathan Medical” ) with 
strain gauge and AC coupler connected to a recorder ("Bioscience” ). The 
subsequent perfusion pressures of the perfusion pump (see Sections 2.5. and 
2.6.) were continually adjusted throughout the experiment so as to 
approximate these readings. 
 
The proximal and distal femoral vessels were divided between “ Liga”  clips, 
thus harvesting the free muscle flap on its vascular pedicle (Plates 3.1A to 
C). This muscle flap (TEST) was then manipulated as described in Sections 
2.5., 2.8. and 2.9. 
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A similar dissection was performed in the opposite groin and the 
contralateral rectus femoris muscle harvested as a CONTROL. The muscle 
was wrapped in a saline soaked-gauze swab and  placed in a container and 
stored at 4 oC in a thermostatically controlled refrigerator. The temperature 
of the refrigerator was monitored using an electronic thermocouple and was 
maintained at the same temperature as that of the perfusate solution.  
 
In one set of experiments, the CONTROL muscle was divided - one half was 
stored at 4 oC as above and the other half was stored using the same method 
but at 25 oC in a thermostatically controlled water bath. This served to 
document the effects of warm ischaemia on the muscle. 
 
After harvesting of the muscle flaps,  the animal was sacrificed using 
intravenous sodium pentobarbitone, 100mg/kg ("Eutha-naze", Centaur 
Laboratory). 
 
2.5. PERFUSION APPARATUS (Plates 2.5.1 and 2.5.2) 
 
A  renal perfusion pump ("Waters  MOX - 100DCM" ,Waters Instruments, 
Inc., Rochester, Mn., USA) was used for pulsatile perfusion of the muscle 
(TEST) flaps which were perfused with oxygenated, cooled "University of 
Wisconsin" solution (UWS) for up to 24 hours (Plates 2.5.1 and 2.5.2).  
 
The “ Waters MOX - 100”   renal preservation system is a gravity-flow 
system in which circulating perfusate returns by gravity from the perfused 
tissue or organ through a venous reservoir, flow meter, enclosed membrane 
envelope, arterial reservoir and to the inlet of the pulsatile pump. 
  
48 
 
48 
 The perfusate is then pumped through a heat exchanger and bubble-trap and 
returned to the perfused tissue or organ. The entire perfusion apparatus 
consists of 2 units:  
 
2.5.1. The Pump - Transport module and console unit  (Plate 2.5.1): 
 
This unit delivers the perfusate at a variable rate (strokes / minute – see Plate 
2.5.1 pulse rate control knob, PRC), which was adjusted to simulate the 
rabbits own heart rate at rest  (75 to 80 pulsations / min.). The perfusion 
pressure is controlled by “  stroke volume”  controller (labelled SVC) and 
displayed on a dial registering in mmHg. This was adjusted according to the 
mean arterial pressures measured by canulating the femoral artery as 
described earlier. The perfusion pressures were continuously recorded as 
discussed in Section 2.6. below. Therefore, perfusion pressures and rate 
were delivered to the flap at physiological values.  
 
The pump has a refrigeration unit (labelled RU) which was thermostatically 
controlled (labelled TC) and delivers cooled perfusate at a desired 
temperature (in this case, 4 oC). This was also monitored continuously using 
a thermocouple (refer Section 2.7.).  
 
Further features of the pump included attachments for inlets so that perfusate 
may be delivered at controlled partial oxygen pressure. A controlled flow of 
oxygen (O2) and carbon dioxide (CO2 ) [see Plates 2.5.1 and 2.5.2] enters 
the membrane oxygenator which is surrounded by a sealed membrane 
oxygenation chamber (labelled MOC) on the cassette. By regulating the flow 
of CO2 and O2,  the system’ s pH and p02  can be controlled . These were also 
monitored at regular intervals (refer Section 2.7.). 
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Plate 2.5.1: Renal preservation system – Waters MOX-100DCM perfusion 
pump (and cassette) 
SVC – stroke volume control knob; PR – pulse rate control knob;  
TC – temperature control knobs (upper and lower limits); O2 – oxygen 
flowmeter (l/min); CO2 – carbon dioxide flowmeter (l/min) 
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2.5.2. The cassette (Plate 2.5.2): 
 
This pre-sterilised disposable plastic cassette contains a complete circulatory 
system and mounts onto the pump unit. 
 
A bubble-trap ensures separation of all trapped air bubbles from the 
perfusate before they reach the perfused tissue or organ. Special fittings are 
provided in the bubble trap and flow lines to permit sampling of the 
perfusate. 
 
Pulsatile flow is provided by a pair of occlusive non-traumatic vinyl plastic 
valves placed in series within a vinyl tube. The chamber between the valves 
is alternatively compressed and released by a cam-driven arm. The pulsatile 
pump is provided with a variable pulse rate control and mechanical control 
for adjusting the stroke volume. 
 
The cassette was primed with approximately 300 ml UWS perfusion solution  
which was allowed to circulate for several hours for equilibration. 
Prior to connecting the muscle flap in the cassette, baseline readings of 
perfusate temperature, pH, PO2, PO2 were obtained. 
 
The organ chamber contains a mesh tray on which the muscle flap was 
placed and 2 inlet ports, which provided the cooled, oxygenated perfusate. 
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Plate 2.5.2: Renal preservation system – Waters MOX-100DCM perfusion 
cassette 
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2.6. PERFUSION TECHNIQUE (Plates 2.6 A to C) 
 
The arterial and venous ends of the vascular pedicle of the muscle flap was 
cannulated with silicone tubing, using magnification so that endothelial 
damage was minimised. A “ Portex”  silicone tube (size No. 140) was used on 
the artery and a No. 200 for the venous end. 
 
 
Plate 2.6 (A): cannulation of rectus femoris muscle flap after harvesting 
RF = rectus femoris muscle flap; VP = vascular pedicle 
 
The cannulated arterial end  of the isolated muscle flap (RF) was connected 
to the perfusion pump and a strain gauge coupler by means of a 3 way tap, so 
that continuous recording of perfusion pressures could be obtained 
throughout perfusion (via inlet port  - see Plates 2.6 (B) and (C)). The 
perfusion pressure was maintained at approximately 100mmHg, as 
determined by the mean arterial blood pressure recorded in the animal's 
femoral artery prior to harvesting the muscle.  
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The effluent from the cannulated venous end of the muscle flap was 
collected at 2 hourly intervals and the flow rates recorded. 
 
In addition to pulsatile perfusion, the muscle was kept moist and cooled by 
topical cooling with the same perfusion solution which washed over the 
muscle from inlet port B (Plates 2.6 (B) and (C)). The isolated muscle flap 
can be seen resting on porous membrane within the perfusion cassette. Plate 
2.6 (C) demonstrates a similar system but utilising a simultaneous double 
flap perfusion technique. 
 
 
 
Plate 2.6 (B): Single flap perfusion technique – perfusion of the muscle flap 
and topical cooling  
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Plate 2.6 (C): Simultaneous double flap perfusion technique– perfusion of 
the muscle flap and topical cooling  
RF – rectus femoris muscle (1 or 2); IP-A – inlet port A; IP-B – inlet port B; 
ac – arterial cannula (1 or 2)  
 
 
2.7. MONITORING 
 
The sampling protocol regarding various aspects of flap monitoring is 
outlined in Table 2. 
 
2.7.1. Temperature: 
The temperature of the perfusate was monitored using an electronic 
thermocouple and maintained at approximately 4 oC. The temperature of the 
refrigerator in which the control muscle was stored was also monitored and 
maintained at a similar temperature to that of the perfusate.  
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2.7.2. Gas Analysis: 
The pH, PO2, PCO2 of the perfusate were determined initially after 
equilibration using a blood gas analyser. The average partial pressures of 
oxygen was maintained at 280 to 300mmHg. The gases were further 
monitored at regular intervals as per sampling protocol.  
 
2.7.3. Perfusion Pressures: 
The perfusion pressures as delivered by the perfusion pump apparatus were 
monitored continuously throughout the 24 hours of perfusion by means of a 
pressure transducer (“ Stathan Medical” ) with strain gauge and AC coupler 
connected to a recorder (“ Bioscience Instruments” ). Pressures were adjusted 
so as to approximate the mean arterial blood pressure in the anaesthetised 
rabbit as discussed above. 
 
2.7.4. Flow: 
Flow was monitored from the effluent of the canulated vein of the flap’ s 
vascular pedicle (“ venous output” ). The rate of flow was measured as 
volumes per unit time, as calculated by the weight of the effluent using a 
“ Sartorius”  balance.  
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Table 2: Sampling protocol for perfused and stored muscle 
 
 
    TIME 
INTERVAL 
   (minutes)  
                                    INTERVENTION 
 
 
       15  perfusion pressures, adjusted as necessary 
       30 perfusion pressures 
flow rates 
       60 as above plus: 
temperature control (perfusate and fridge)  
gas analysis  
      120 above plus: 
tissue sampling (refer Section 2.9.) 
 
 
 
 
 
2.8. FLUORESCEINE STUDY 
 
In order to determine whether the perfusate solution had perfused the entire 
muscle, a fluoresceine dye injection test was performed on one rabbit rectus 
femoris muscle. 
 
1 ml of fluoresceine was added to the perfusate using the same study design 
as above. After 5 minutes, the perfusion was halted and the muscle was 
sectioned in both the longitudinal and transverse planes. This was then 
illuminated with a Wood’ s lamp and the green-yellow fluorescence of the 
muscle fibres noted (refer Plates 3.4 (A) and (B)).  
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2.9. TISSUE SAMPLING 
 
Sampling of both TEST and CONTROL muscles were performed during 
perfusion and storage respectively at 0, 4, 8, 12, 18 and 24 hours. 
A 1 cm cylinder of muscle was isolated between two silk sutures and then 
harvested atraumatically by excision on either side of the suture. The muscle 
was then placed on a wooden spatula and the sutures tied behind the spatula. 
This technique preserved resting length and thus prevented contraction 
artefact.  
All tissue samples were immediately processed (as described below) and 
were submitted to Dr. V. Fabian and Mrs. G. Norman at the South African 
Institute for Medical Research, Johannesburg, South Africa, for histological 
and electron microscopic analysis. 
 
Biopsy tissue for light microscopy were immediately placed in neutral 
formalin fixative (pH 7,4). Paraffin embedded tissue was sectioned and 
stained with Haematoxylin and Eosin. 
 
Tissue for electron microscopy was fixed in 3% glutaraldehyde and 4% 
formaldehyde (Karnovsky,1965) in Millonig's phosphate buffer. After 
rinsing in buffer alone, post-fixation was carried out in 1% osmium 
tetroxide, buffered in Millonig's solution for 1 hour. Following further 
rinsing in buffer, the tissue was dehydrated in a graded series of ethanol’ s 
prior to infiltration with Spurr resin. Polymerisation took place for 3 hours at 
100 oC. Thin sections (60nm) were stained with alcoholic saturated uranyl 
acetate and alkaline lead citrate at pH 13,5. Sections were mounted on 
copper grids and examined using a  transmission electron microscope 
(“ Hitachi H600” ). 
  
58 
 
58 
2.10. ANALYSIS AND EXPERIMENTAL OBSERVATIONS OF 
PERFUSED AND STORED MUSCLE 
 
2.10.1. Light Microscopic Assessment (LM) 
 
Each of the prepared histological specimens (TEST and CONTROL) were 
evaluated blindly and independently by Dr.’ s V. Fabian and G. De Aguiar. 
A modification of the grading system as described by Harman (1947), was 
used. 
One hundred muscle fibres in ten randomly selected high power fields at 
400x magnification (i.e. 10 muscle fibres in each high power field), were 
examined for the presence of changes reflecting ischaemic damage in 3 
areas: 
1.  cross striations or overall banding pattern of the muscle fibre - being 
either preserved (normal), or wavy or absent (abnormal). 
2.  cytoplasmic changes - being either normal or showing the abnormal 
features of homogenous or granular necrosis. 
3.  nuclear changes - being either normal or showing the pathological 
features of pyknosis or karyolysis (absent nucleus). 
 The normal muscle fibre was arbitrarily assigned 1 point and the muscle 
fibre with ischaemic changes was assigned 0 points. Therefore, for each 
"ischaemic feature" (1, 2, or 3 above) , a total score of 100 was possible if no 
features of ischaemic damage were present. If all 3 features were normal, an 
overall score of 300 was possible. Thus, scores could range from 0 
(indicating presence of all 3 categories of ischaemic damage in all of the 
fibres) to 300 points (indicating no structural changes). This was divided by 
3 to give an overall percentage of normal versus abnormal or ischaemic 
muscle fibres (Table 3). Typical examples of these light microscopic criteria 
are depicted in Plates 3.5.2 (A) – (D). 
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Table 3: Grading system for muscle ischaemia on light microscopy 
 
      LIGHT MICROSCOPIC FEATURE        SCORE                      
   
(points/fibre) 
1. BANDING PATTERN (cross striations) 
     normal (preserved) 
     abnormal (wavy or absent striations) 
 
            1  
            0 
 
2. CYTOPLASM 
     normal (unchanged) 
     abnormal (homogenous or granular necrosis) 
 
            1 
            0 
 
3. NUCLEUS 
     normal (unchanged) 
     abnormal (pyknotic or absent) 
 
            1 
            0 
 
 
       TOTAL SCORE OBTAINED BY ANALYSING 100 MUSCLE FIBRES 
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2.10.2. Electron Microscopic Assessment (EM) 
 
Each of the electron micrographs on the prepared samples were examined 
blindly and independently by 2 electron microscopists and 1 pathologist.  
 
A quantitative electron microscopic grading system was based on 7 changes 
which reflect of ischaemic damage and /or necrosis. These changes were 
selected as they provide an overall picture of the effects of ischaemia on 
skeletal muscle and show a wide spectrum of changes ranging from early 
(mitochondrial) to late (architectural) changes. 
 
The features were recorded in each of the micrographs and ranged from an 
arbitrary number of 10 points (if the feature was entirely normal) to 0 points 
(indicating the presence of ischaemic damage). An entirely normal muscle 
fibre could thus obtain a score of 70 points, whereas the totally ischaemic 
fibre scores zero. The points obtained overall were converted to percentages. 
The electron microscopic grading system is shown in Table 4. 
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Table 4: Grading system for muscle ischaemia on electron microscopy 
 
  ELECTRON MICROSCOPIC FEATURE        SCORE     
(points/fibre) 
1. OVERALL ARCHITECTURE OF FIBRE 
normal (architecture retained; preserved Z / I bands)          
abnormal (architecture disrupted) 
 
            10 
            
             0 
2. SARCOPLASMIC RETICULUM 
tubules undilated 
tubules dilated 
 
            10 
             0 
3. MYOFIBRILLAR ORGANISATION 
normal organisation 
disorganisation (focal or general) 
 
            10 
             0 
4. MYOFIBRILLAR LOSS 
no loss 
focal loss 
extensive loss 
 
            10 
             5 
             0 
5. GLYCOGEN CONTENT 
normal 
decreased 
absent 
 
            10 
             5 
             0 
6. BASEMENT MEMBRANE 
intact 
disrupted 
 
            10 
             0 
7. MITOCHONDRIA 
normal appearance 
slightly swollen, internal cristae intact 
50% of mitochondria intact 
degenerate 
 
            10 
            7,5 
             5 
             0 
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2.10.3. Overall Score Combining Light and Electron Microscopy (LM 
plus EM) 
 
The overall percentage of survival of muscle fibres (and conversely, the 
overall percentage of ischaemic damaged fibres) were obtained by adding the 
percentage of the light microscopic scores (based on the 3 LM features) and 
electron microscopic scores (based on the 7 EM features). An overall global 
quantification of the degree of ischaemic survival or damage was obtained on 
the combined 10 criteria (LM plus EM). This, we believe, provides a true 
representation of ischaemic damage in skeletal muscle. 
 
2.11. STATISTICAL ANALYSIS 
 
Statistical analysis of all light and electron microscopic data (muscle survival 
or ischaemic damage) were conducted independently by Dr. P. Bekker and 
Mrs. E. Viljoen of the University of the Witwatersrand Biostatistics 
Department. 
 
The experiment was conducted and analysed as a two-factor within design, 
the two within main effects being PERFUSION (with levels perfused and not 
perfused ) and TIME (with levels 0, 4, 8, 12, 18, 24 hours). 
 
The response variable was percentage muscle survival as assessed by light 
and electron microscopy respectively and as a combination of the two 
(overall muscle survival). Inter-group quantitative data was analysed on a 
computer with appropriate analysis of variance (ANOVA), so as to provide 
an analysis of the total data. 
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When TIME was found to be significant (i.e. some of the levels are different 
from one another), contrasts were tested to assess pairwise differences 
between individual times. Also of interest was to compare the levels of 
PERFUSION at the specific times. This was done using a Student’ s t-test. 
 
2.12. ETHICAL CONSIDERATIONS 
 
This study was submitted to and approved by the Animal Ethics Committee 
of the University of the Witwatersrand, Johannesburg, South Africa (Ethics 
clearance No. 92/112/2b). 
 
 The study was conducted in the University of the Witwatersrand Central 
Animal Service under the supervision of a qualified veterinarian, Dr. S. 
Maeder.  
 
All surgery was performed under general anaesthesia. After harvesting the 
muscle flap, the animals were humanely sacrificed by means of an 
intravenous bolus of sodium pentobarbitone, 100mg/kg ("Eutha-naze", 
Centaur Labs).  
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Figure 2: Animal Ethics Clearance Certificate 
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CHAPTER 3 -  RESULTS 
 
3.1. ANATOMY OF THE RECTUS FEMORIS MUSCLE FLAP AND 
ITS VASCULAR SUPPLY (Plates 3.1 A – C) 
 
Plate 3.1(A) demonstrates the typical dissection of the muscle flap in the 
groin. The inguinal ligament (IL) marks the superior aspect of the groin, 
above which is the fat pad in the groin. The central area of Plate 3.1(A) 
shows the anterior thigh region and the most inferior aspect is the knee area. 
The rectus femoris muscle (RF) has been mobilised after the insertion at the 
knee has been divided. The muscle flap has been reflected superiorly (thus 
showing its posterior aspect) to demonstrate the vascular anatomy. The 
superficial femoral vessels (FVS) and the vascular pedicle (VP) to the flap 
are demonstrated by white markers. 
 
 
Plate 3.1(A): Dissection of rectus femoris muscle flap 
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The vascular pedicle to the rectus femoris muscle was identified and 
carefully preserved  - see Plates 3.1 (B) and (C).  
 
Plate 3.1(B) demonstrates the vascular pedicle to the muscle. A white 
marker (VP) points to the vascular pedicle to the rectus femoris muscle flap 
(RF). White visibility background material has been placed under the 
pedicle. 
 
The pedicle to the flap was noted to leave the femoral vessels on their lateral 
aspect at a variable distance (approximately 3 to 10mm) below the inguinal 
ligament (IL). A second white marker (FVS) points to the superficial femoral 
vascular bundle. A clear polyethylene vessel loop has been placed around the 
femoral artery (FA). The femoral artery and vein then give branches and 
tributaries respectively to the muscle flap (FaP and FvP respectively), which 
forms the vascular pedicle to the flap. These vessels then entered the muscle 
on its medial aspect (see Plate 3.1(C)) and continued along the length of the 
surface of the muscle as an axialised system of vessels (AV), sending 
perforating branches into the depths of the muscle. 
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Plate 3.1(B): Femoral vessels and vascular pedicle of the muscle flap 
 
 
Plate 3.1(C): Axial vascular system of rectus femoris muscle 
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The proximal part of the superficial femoral artery and vein were controlled 
separately on vessel loops, whilst the distal vessels were ligated 1 to 2 cm 
below the vascular pedicle to the muscle (refer Plates 3.1(B) to (C)). Sparing 
the pedicle, ligation of the various branches of the femoral system was 
performed using “ Liga”  clips. These branches included: 
1. A supero-lateral branch entering the muscle near its insertion 
2. A medial branch entering the adductor muscles, approximately 15 to 20 
mm below the inguinal ligament. 
3. A lateral branch distal to the pedicle, entering the remainder of the 
quadriceps group of muscles. 
4. A smaller twig leaving the inferior aspect of the pedicle itself and 
supplying the closely applied adductors. 
5. A variable system of vessels around the posterior aspect of the proximal 
femoral artery and vein, several millimetres distal to the inguinal ligament. 
 
 
3.2. RADIOGRAPHIC STUDY (Plates 3.2 A and B) 
 
In the first study (Plate 3.2(A)), the right femoral vessels were isolated and 
then ligated just distal to the inguinal ligament. The left femoral vessels were 
undisturbed and served as the control. The flush aortagram showed no distal 
flow beyond the ligated femoral artery at this level. Although a single medial 
branch of the femoral artery remained patent, an adequate collateral 
circulation is not present and no distal runoff occurs as compared to the 
control side. If the rectus femoris muscle flap was to be isolated by ligation 
of the femoral vessels at this level, the distal limb would have been rendered 
ischaemic.  
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In the second study (Plate 3.2(B)), the vascular pedicle to the rectus femoris 
muscle flap was dissected and the muscle flap isolated as an island pedicle 
flap. The direct vascular pedicle to the muscle was ligated with the distal 
femoral artery remaining patent. The contrast medium perfused the distal 
limb with distal runoff remaining essentially the same as the control side. 
This demonstration has shown that, provided the vascular pedicle to the 
rectus femoris muscle was ligated only, distal vasculature remains 
undisturbed and the lower limb would not be rendered ischaemic. 
 
This has bearing in future in-vivo experimentation and is of relevance if 
microsurgical transplantation requires the animal not to be sacrificed. 
Further research could involve re-attaching the perfused muscle into the 
contralateral groin by microvascular replantation so as to determine the 
effects after in-vivo reperfusion. If the distal limb is to remain viable, the 
harvest of the muscle flap and/or anastomosis must take place at the level of 
the vascular pedicle to the muscle flap and not at the femoral vessel level. 
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Plate 3.2(A): Radiographic study of arterial anatomy to lower limbs – 
ligation of right femoral artery distal to inguinal ligament 
NOTE: poor distal runoff of right lower limb 
  
 
Plate 3.2(B): Radiographic study of arterial anatomy to lower limbs – 
isolated right-sided ligation of pedicle to muscle flap 
NOTE: preserved distal runoff to entire lower limb
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3.3. PERFUSION STUDIES 
 
3.3.1. Gas Analysis 
It was generally noted that PO2 and PCO2 remained stable throughout the 24 
hours of perfusion, largely due to the buffering capacity of UWS. The pH 
values of the 5 perfused flaps at 24 hours, averaged 7,18 with a range of 7,12 
- 7,23. The pH of the UW solution is made to 7,40 at 25 oC and is a 
phosphate buffered system. In this series of experimental studies conducted 
with cooled UWS (4 oC), baseline pH readings of 7,30 were found 
universally. The possible protective role of mild acidosis has been discussed 
(section 1.4.4.). 
 
3.3.2. Flow 
Flow rates were measured over the 24 hour period in the 5 perfused flaps. 
The average flow rate of perfusate from the flap measured 0,610 ml/minute 
(range 0,243 - 1,010 ml/min). 
 
3.4. FLUORESCEINE STUDY (Plates 3.4 A and B) 
 
The rectus femoris muscle is shown in its entirety prior to sectioning (Plate 
3.4 (A)) as it appeared under Wood’ s ultraviolet illumination. The entire 
surface shows the characteristic yellowish-green colouration, confirming that 
the perfusate has reached the superficial areas of the muscle. The sectioned 
muscle (Plate 3.4 (B)) confirmed that the solution had perfused the entire 
muscle. This suggested that all muscle units or fibres are perfused to a 
similar degree and are therefore susceptible to the effects of any perfusion 
solution to a similar degree. Furthermore, this study illustrates that muscle 
biopsies contain a representative sample regardless of the site of tissue 
biopsy. 
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Plate 3.4 (A): Fluoresceine study – intact rectus femoris muscle flap  
 
 
 
 
 
Plate 3.4 (B): Fluoresceine study – rectus femoris muscle flap: sectioned 
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3.5. DEMONSTRATION OF ISCHAEMIC MUSCLE GRADING 
SYSTEM AND MUSCLE FLAP STUDIES  
 
3.5.1. Gross Pathology 
 
The overall gross appearance of the muscle flaps after 24 hours of cold 
perfusion with UWS, simple cold storage and storage at 25 oC (from left to 
right respectively), are shown in Plate 3.5.1.  
 
The perfused flap appeared to be moist and pale pink in colour, with no overt 
necrosis. The flap subjected to simple cold storage at 4 oC appeared to be 
contracted and desiccated with an overall appearance of tissue dehydration. 
The flap subjected to warm ischaemia showed extreme desiccation and had a 
grey-white appearance representative of non-viable muscle. Although this 
plate shows the muscle subjected to 24 hours of warm ischaemia (25 oC), 
similar gross macroscopic findings were seen in muscle stored at room 
temperature for only 8 hours. 
Although gross macroscopic appearance does not provide an accurate 
assessment of tissue viability, it does allow for some appreciation of the 
clinical overall viability of the muscle flaps. 
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Plate 3.5.1: Gross macroscopic appearance of the perfused, cold-stored and 
warm-stored rectus femoris muscle after 24 hours
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3.5.2.  Light Microscopy 
 
The percentage of muscle survival as seen on light microscopy (as analysed 
according to the assessment criteria detailed in Table 3), was assessed by 
means of a pairwise comparison between the TEST (perfused) and 
CONTROL (stored) muscle. This was performed at TIMES of 0, 4, 8, 12, 18 
and 24 hours.  
 
The means, standard deviations and P-values are tabulated in Table 5 and 
illustrated in Figure 3. 
 
 
Table 5: Percentage of muscle survival of TEST and CONTROL muscle on 
light microscopy 
 
TIME 
(hour) 
          TEST  
   %   survival   
mean  (+/-  SD) 
  CONTROL  
  % survival 
  mean  (+/- SD) 
     
p- VALUE 
       0           100 (0)          100 (0) 1.0000 
       4         95,2    
(4,76) 
         76,4 
(9,56) 
0,0013 ** 
       8         85,4 (9,15)        73,4 
(7,60) 
0,0044 ** 
      12         83,2 (8,07)        54,0 
(8,22) 
0,0090 ** 
      18         69,8 (5,40)      43,0 (10,17) 0,0068 ** 
      24         55,8 (5,17)      25,6 (14,59) 0,0103 ** 
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     ** - highly statistically significant (at a 1% level of significance)  
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Figure 3: Percentage of muscle survival for TEST vs. CONTROL muscle on 
light microscopy  
 
Plates 3.5.2 A - D are photomicrographs of the rectus femoris muscle, 
illustrating typical light microscopy findings at various time intervals and 
temperatures (Haematoxylin and Eosin staining technique, 400x). 
 
Plate 3.5.2 (A) shows an example of a NORMAL rectus femoris muscle (in 
this case, a sectioned muscle at time interval 0 hours or pre-ischaemia). 
The 3 important light microscopic features are clearly illustrated.  
Note the cross striations (CS) or normal banding pattern of the muscle. These 
are crisp, broad and well defined.  
The cytoplasm (CP) is seen to be clear and even, without a granular or 
diffuse homogenous appearance.  
The nuclei (N) are seen to be clear and well defined and the nucleoli are 
visible in this micrograph. 
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Plate 3.5.2 (A): Photomicrograph of normal rectus femoris muscle fibres 
(pre-ischaemia); H & E stain, 400x 
CS – cross striations; CP – cytoplasm; N – nuclei 
Plates 3.5.2 (B) and (C) provide interesting comparative studies of warm 
and cold perfused muscles at various time intervals. 
  
Plate (B) demonstrates muscle fibres which have been subjected to 8 hours 
of warm ischaemia (WARM CONTROL). Although the banding pattern is 
preserved in some fibres, most take on a homogenous appearance (H) and a 
distinct granularity (G) of the cytoplasm is present. The nuclei are shrivelled 
and pyknotic (PN) and are absent from some fibres. This muscle is not 
viable. 
 
 
 
 
Plate 3.5.2 (B): Photomicrograph of muscle stored at room temperature (at 
250C) for 8 hours (warm control); H & E stain, 400x 
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Plates C and D demonstrate interesting comparisons, and show muscle 
fibres at 24 hours for both cold stored (CONTROL)and perfused (TEST) 
muscles respectively. 
 
Plate 3.5.2 (C) (cold stored, 24 hours) show all the LM features of necrotic 
muscle with absent or pyknotic nuclei (PN), and granular or homogenous 
appearance to the cytoplasm (G, H). 
 
 
 
 
Plate 3.5.2 (C): Photomicrograph of muscle subjected to 24 hours of 
cold-storage (at 40C); H & E, 400x 
H – homogenous cytoplasm; G – granular necrosis of cytoplasm; PN – 
pyknotic nuclei 
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Plate 3.5.2 (D) demonstrates typical findings of muscle that has been 
perfused for 24 hours. The cross striations (CS) are preserved in several 
fibres (60% of fibres in this high power field) with the remainder been 
replaced by a homogenous appearance to the cytoplasm (H). No granular 
necrosis (as noted in the cold stored muscle at 24 hours) was present. The 
nuclei are well preserved, with the nucleoli clearly visible (N). Although this 
muscle has been damaged by ischaemia, the presence of normal nuclei and 
patchy preservation of cross striations make this a viable muscle. Despite a 
more than doubled ischaemic time, the cold perfused muscle survives better 
than the muscle kept at room temperature.  
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Plate 3.5.2 (D): Photomicrograph of muscle subjected to 24 hours of cold 
perfusion with UWS at 40C; H & E stain, 400x 
CS  - cross striations; H – homogeneous cytoplasm; N – nuclei 
3.5.3.  Electron Microscopy: 
The percentage of muscle survival as seen on electron microscopy (as 
analysed according to the assessment criteria detailed in Table 4), was 
assessed by means of pairwise comparison between TEST and CONTROL 
muscle as for 3.3.2. above. 
 
The results are depicted in Table 6 and in Figure 4. 
 
 
Table 6: Percentage of muscle survival for TEST vs. CONTROL muscle on 
electron microscopy 
 
   TIME 
  (hours) 
            TEST 
      % SURVIVAL 
       mean (+/- SD) 
        CONTROL 
      % SURVIVAL 
      mean (+/- SD) 
     P–
VALUE 
      0            100 (0)           100 (0) 1,0000 
      4            97,14 (6,40)           90,02 (8,14) 0,0345 * 
      8            86,44 (12,47)           82,84 (11,96) 0,3703 
     12            80,72 (3,17)           67,14 (4,71) 0,0374 * 
     18            76,42 (9,31)           55,70 (7,38) 0,0398 * 
     24            60,00 (5,87)           37,14 (10,28) 0,0262 * 
 
        * - statistically significant (at a 5 % level of significance) 
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Figure 4: Percentage of muscle survival for TEST vs. CONTROL muscle on 
electron microscopy 
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In order to understand the ultrastructural derangement’ s of the myofibril 
when subjected to an ischaemic insult, one must first examine the normal 
architecture of muscle as seen on electron microscopy. The following 
description and diagrams (Figures 5 and 6; Plate 3.5.3 (A)) allow us to 
familiarise with the overall arrangement of the myofibrils and the conducting 
system of normal skeletal muscle.  
 
Under the electron microscope, the arrangement of the contractile proteins 
and the conducting system may be seen.  
The sarcomere consists of two types of myofilaments, thick and thin 
filaments. Each type remains constant in length regardless of the state of 
contraction of the muscle. The filaments are arranged in a symmetrical 
interdigitating manner parallel to the long axis of the myofibril. The thick 
filaments, which are composed mainly of the protein myosin, are maintained 
in parallel by their attachment to a disc-like zone represented by the M band. 
These thick filaments can be seen on EM as dark A bands. 
 
Similarly, the thin filaments, which are composed mainly of the protein 
actin, are united in a disc-like zone represented by the Z band. These thin 
filaments can be seen as light I bands under the electron microscope. 
The I and H bands, both areas of low electron-density, represent areas where 
thick and thin filaments do not overlap one another. 
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Figure 5: Overall arrangement of myofibrils and myofilaments of normal 
skeletal muscle (after Wheater et al, 1979) 
 
 
 
Plate 3.5.3 (A): Electron micrograph of a normal rectus femoris muscle; 
50 000x    A – dark band; I – light band; M – m line; Z – Z line 
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To permit synchronous contraction of all sarcomeres in the muscle fibre, a 
system of tubular extensions of the muscle cell membrane or sarcolemma 
extends transversely into the muscle cell to surround each myofibril in the 
region of the junction of the A and I bands. Thus, throughout the muscle 
fibre, there is a tubular system, the T system, the lumen of which is 
continuous with the extracellular space.  
 
Closely associated, but not connected with each T tubule system, there are 
two complementary membrane systems derived from smooth endoplasmic 
reticulum. These are called sarcoplasmic reticulum. They ramify to form a 
membranous network which embraces each myofibril. Each T tubule, with 
its pair of associated sarcoplasmic reticulum elements called terminal 
cisternae, form a triad near the junction of the I and A bands of each 
sarcomere. 
 
 
 
Figure 6: Architecture and conducting system of the myofibril of skeletal 
muscle (after Wheater et al, 1979) 
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We  may now examine typical electron microscopic findings of the rectus 
femoris muscle in this study. Plates 3.5.3 (B) – (G) depict electron 
micrographs of findings of muscle subjected to varying ischaemic intervals 
and temperatures.  
 
Plate 3.5.3 (B) is an electron micrograph demonstrating the normal rectus 
femoris muscle, prior to any ischaemic insult. The overall architecture is 
preserved, with organised myofibrils and well-defined Z and I bands.  
 
 
 
Plate 3.5.3 (B): Electron micrograph of normal muscle (pre-ischaemia);  
52 500x 
G – glycogen granules; M – mitochondria; BMB - basement membranes;  
TT – T tubules  
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Plates 3.5.3 (C) – (E) show the muscle subjected to various interventions but 
all at 8 hours of ischaemia.  
 
Plate 3.5.3 (C) shows the cold perfused muscle (TEST). Findings are as for 
normal muscle as shown in Plates 3.5.3 (A) and (B). Therefore, for periods 
up to 8 hours, cold perfusion has a definite preservation effect and no 
ischaemic damage is seen. 
 
 
 
Plate 3.5.3 (C): Electron micrograph of muscle subjected to 8 hours of cold 
perfusion (40C); 50 000x 
M - mitochondria
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Plate 3.5.3 (D) depicts muscle subjected to 8 hours of simple cold storage 
(COLD CONTROL). Glycogen content is depleted and the mitochondria are 
swollen, with disruption of the internal cristae (IC). The overall architecture 
remains preserved. This muscle, although showing ischaemic changes, 
remains viable. 
 
 
 
 
Plate 3.5.3 (D): Electron micrograph of muscle subjected to 8 hours of cold 
storage (40C); 35 000x
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Plate 3.5.5 (E) depicts muscle subjected to 8 hours of warm ischaemia. The 
overall architecture is disrupted with disruption of the basement membrane. 
Myofibrils are less numerous than the cooled muscles (myofibrillar loss). 
Glycogen is absent and the tubules (T) of the sarcoplasmic reticulae are 
dilated. The mitochondria are degenerate and the black dots within them 
indicate severe hypoxic changes.  
This muscle is non-viable. 
 
 
 
 
Plate 3.5.3 (E): Electron micrograph of muscle after 8 hours of warm 
ischaemia (250C); 36 000x
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Plates 3.5.3 (F) and (G) provide interesting contrasts, and show muscle 
subjected to 24 hours of ischaemia.  
 
Plate 3.5.3 (F) shows the cold stored muscle (CONTROL, 24 hours) and 
Plate 3.5.3 (G) depicts the perfused muscle (TEST, 24 hours). 
 
The cold stored muscle (F) is rendered necrotic after 24 hours of cold 
ischaemia without perfusion with UWS. There is gross disruption of the 
architecture with a disorganised overall appearance. The basement 
membranes are shattered, tubules are dilated and the mitochondria are 
swollen, have no internal cristae and are degenerate. All 7 of the EM features 
show a non-viable picture. 
 
 
Plate 3.5.3 (F): Electron micrograph of muscle after 24 hours of cold storage 
(CONTROL); 21 000x      
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In contrast to this, although the perfused muscle (G) has suffered some 
ischaemic damage, the gross architecture is preserved. There has been some 
mitochondrial hypoxic damage (as evidenced by mitochondrial swelling), 
there is but they are not degenerate and their internal cristae are intact. The 
glycogen granules are depleted, although can be seen in places. The 
remaining of the EM features are generally intact and the myofibrils and 
basement membrane remains unaffected. This muscle is viable.  
The EM features of muscle after 24 hours of perfusion show similar changes 
to the muscle that is cold stored for only 12 hours (refer Table 6). Perfusion 
therefore has prolonged ischaemic survival almost twofold. 
 
 
          
Plate 3.5.3 (G): Electron micrograph of muscle after 24 hours of cold 
perfusion (TEST); 17 000x 
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3.5.4.  Combined Assessment of Muscle Survival (LM + EM): 
An overall assessment of the percentage of muscle survival was performed 
by combining the results obtained on light and electron microscopy based on 
the 10 features (3 LM and 7 EM) as described earlier (Section 2.10.).  
 
This provides an overall global assessment of ischaemic muscle survival for 
each time interval and is depicted as pairwise comparisons as means and 
standard deviations in Table 7 and Figure 5. 
 
 
Table 7: Percentage of muscle survival for TEST vs. CONTROL muscle on 
combined light and electron microscopy 
 
 
  TIME       
(hours) 
          TEST   
   % SURVIVAL 
  mean (+/- SD) 
      CONTROL 
    % SURVIVAL 
       mean (+/-SD) 
p–
VALUE 
      0            100 (0)           100 (0) 1,0000 
      4            96,17 (3,30)           83,21 (2,35) 0,0006 ** 
      8            85,92 (10,59)           78,12 (7,50) 0,0103 ** 
     12            81,96 (5,60)           60,57 (3,65) 0,0013 ** 
     18            73,11 (2,52)           49,35 (7,53) 0,0025 ** 
     24            57,90 (2,50)           31,37 (11,40) 0,0084 ** 
 
 
         ** - highly statistically significant (at a 1% level of significance) 
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Figure 7: Overall percentage of muscle survival (combined light and 
electron microscopy) 
3.5.5  Contrasts and Interactions Between Groups and Times 
 
An ANOVA test was performed to assess whether the interaction between 
the groups and times were significantly different, as expressed by gt (group- 
time). This is depicted in Table 8.  
 
These data represent the overall combined electron and light microscopic 
findings of ischaemic survival, thus providing a global illustration of group - 
time interactions. All results were at 1 degree of freedom. 
 
It is important to note that for all time groups beyond 0 hours, the TEST 
(perfused) group survives statistically better than the CONTROL (cold 
stored) group. One notable exception is the electron microscopy results at 8 
hours where no statistical difference between TEST and CONTROL groups 
was found. The group – time interaction serves to determine which group 
deteriorates more rapidly for a particular TIME (refer Section 4.3.).  
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Table 8: Contrasts between groups and times for combined light and 
electron microscopic assessment 
 
         GROUPS / TIMES 
 
         P – VALUE 
t4 – t8 
gt 
0,0579 
0,1326 
t4 – t12 
gt 
0,0004 ** 
0,0650 
t4 – t18 
gt 
0,0006 ** 
0,0725 
t4 – t24 
gt 
0,0003 ** 
0,0892 
t8 – t12 
gt 
0,0251 * 
0,0010 ** 
t8 – t18 
gt 
0,0098 ** 
0,0018 ** 
t8 – t24 
gt 
0,0035 ** 
0,0118 * 
t12 – t18 
gt 
0,0026 ** 
0,5021 
t12 – t24 
gt 
0,0011 ** 
0,3631 
t18 – t24 
gt 
0,0010 ** 
0,3429 
 
 
* - significant (at a 5% level of significance) 
** - highly significant (at a 1% level of significance) 
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CHAPTER 4   -  DISCUSSION 
 
4.1. Anatomy Of The Rectus Femoris Muscle Flap And Its Vascular 
Supply (refer “  MATERIALS AND METHODS”, Plates 2.6 A – C; 
“ RESULTS”, Plates 3.1 A – C; 3.2 A - B) 
 
In their landmark paper, Mathes & Nahai (1981) classified  human skeletal 
muscle flaps based on their vascular supply. This was important because it 
allowed the reconstructive surgeon to safely dissect and raise various muscle 
flaps based on a knowledge of the vascular pedicles. It afforded 
predictability with regards which vessels could or could not be ligated and 
on which pedicle/s the muscle largely relied upon. With microsurgical 
reconstruction, it is imperative to have a knowledge of the major vascular 
pedicle prior to use of a muscle flap. This classification is depicted in Figure 
4.1. 
 
The anatomical dissection and angiographic studies (Plates 2.6 A-C; 3.1 A-
C and 3.2 A - B) demonstrate that the Mathes & Nahai Classification (1981) 
of the rectus femoris flap in the rabbit would be a Type 1 flap – i.e. a single 
dominant pedicle. It is therefore a useful flap for microsurgery and for 
pharmacological studies as the muscle flap can be isolated entirely on this 
single pedicle and manipulated as required. 
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Figure 8: Patterns of Vascular Anatomy (after Mathes & Nahai, 1981) 
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4.2. CURRENT STUDY ON ISCHAEMIC SURVIVAL OF MUSCLE  
 
This study served to demonstrate the effects of cryoperfusion with UWS 
(TEST) compared to those of simple cold storage (CONTROL). The end-
points used reflected ischaemic survival on light and electron microscopy 
and a combination of both. The parameters of ischaemic damage include 
those features which were felt to be quintessential. A new grading system of 
ischaemia is offered (refer Section 1.4.7.).  
 
The concept of muscle survival following reperfusion is interesting and 
merits further work. After a known period of ischaemia, the recovery or the 
deterioration of muscle after re-anastomosis and reperfusion could provide 
illuminating data. A critical “ cut-off”  point of non-survival could be 
documented. This could be related to this current study, in which the 
percentage of muscle survival (as reflected on LM + EM) may correlate with 
overall muscle recovery and thus, survival. 
 
On  LIGHT MICROSCOPY (Table 5, Figure 3, Plates 3.5.2 (A)- (D) ), a 
highly statistically significant difference in percentage survival between the 
TEST and CONTROL groups was noted for all time intervals beyond 4 
hours (at a 1% level of significance). Muscle which was cold stored 
deteriorated even after 4 hours, with percentage survival of approximately 75 
- 70% at 4 and 8 hours. After 8 hours, considerable deterioration was noted 
in the stored muscle to the point that only half the muscle fibres survived at 
12 hours. At 24 hours, only 25% survival was seen in this group, whilst the 
perfused muscle (TEST) showed a two-fold improvement in survival of 
muscle cells (56%). 
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The more sensitive and specific ELECTRON MICROSCOPIC analysis 
(Table 6, Figure 4, Plates 3.5.3 (B) - (G) ) demonstrates some interesting 
findings. 
The differences in survival between the 2 groups is again significant at 4 
hours (at a 5% level of significance) yet not significant at 8 hours, with 86% 
survival noted in the perfused group and 83% survival in the stored group. 
This may suggest that management of ischaemic muscle with less than 8 
hours duration of ischaemia could well be managed along traditional lines of 
cold storage without perfusion (although perfusion does no harm and shows 
slight improvement of survival). However, the spurious result at 8 hours may 
well be due to the wide standard deviation of +/- 12 as a result of the small 
sample size. After 8 hours, a significant difference in survival is noted 
between the 2 groups (at a 5% level of significance). Even after 24 hours of 
ischaemia, perfused muscle showed a 60% survival compared to 37% if cold 
stored. 
The most accurate assessment of muscle ischaemia is the combined scoring 
system. Based on this, a highly significant difference in survival is noted 
between the perfused and stored groups from 4 hours onwards.  
At 24 hours, a two-fold improvement in survival rates is demonstrated 
(approximately 60% for perfused muscle vs. 31% for stored muscle). 
Furthermore, stored muscle shows the same survival rate at 12 hours as does 
the perfused muscle at 24 hours. 
This study has demonstrated conclusively that perfusion of isolated skeletal 
muscle with cooled oxygenated UWS offers significant survival benefits 
beyond 4 hours. After 8 hours, cold perfusion confers highly significant 
benefits on ischaemic survival as compared to simple cold storage. 
With extended periods of ischaemia (1 day), perfusion can double the 
ischaemic survival or for the same % survival, double the duration of 
survival (beyond 12 hours). 
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4.3. GROUP – TIME INTERACTION ANALYSIS 
 
The analysis of the GROUP – TIME (gt) interaction (Table 8) illustrates 
several interesting facts.  
 
Firstly, with the exception of times 4 compared with 8 hours, ischaemic 
survival is significantly different when each time is compared to another 
regardless of test or control groups (total numbers of test and control results 
are combined respectively and one is only comparing differences at varying 
times). In this case, 4 hours survives statistically better than 12 hours and so 
on, regardless of test or control groups. There is no statistically significant 
difference in survival when 4 is compared with 8 hours (gt = 0,1326 which is 
greater than a p-value of 0,05 which is the minimum cut-off for significance 
at 95%confidence limits).  
 
In both TEST and CONTROL groups, a significant difference in survival is 
seen beyond 8 hours. Therefore regardless of whether one cold perfuses or 
cold stores muscle, survival deteriorates after 8 hours. It is interesting to note 
that cold treated muscle (by whatever means) only survives well for up to 8 
hours. Muscle stored at room temperature (25 OC ) will be grossly necrotic 
well short of 8 hours (see Section 3.5.1.). Warm ischaemia beyond 2 to 4 
hours is likely to show deleterious changes.  
This has direct bearing on the clinical setting where amputated muscle-
containing parts or free muscle transfers should only be subjected to the 
minimum periods of warm ischaemia (certainly less that 4 hours). 
Topical cooling of an amputated limb or elevated free skeletal muscle flap, 
therefore, should be employed in all cases.  
When cold stored, up to 8 hours is compatible with very little ischaemic 
damage (refer Plates 3.5.3 (C) - (E)).  
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We have therefore discussed important cut-off TIMES for muscle subjected 
to cold storage, by whatever means (simple cold storage or cold perfusion). 
Eight hours appears to be a critical time event.  
This is particularly seen on electron microscopy, where no statistical 
difference could be  demonstrated at  8 hours for both TEST and CONTROL 
groups (p = 0,3703). When the light microscopic criteria and 10 overall 
combined criteria (LM + EM) are used, a significant difference between the 
2 groups was noted at all time periods beyond 0 hours. However, 8 hours 
appears to a “ cut-off”  time period after which deterioration is greater in the 
cold stored group. 
 
It is now prudent to examine whether, for a given time, one method of 
cryopreservation yields superior results compared with the other. The 
performance of simple cold storage (CONTROL) is compared to that of cold 
perfusion with UWS (TEST). This is analysed by using the ANOVA group-
time (gt) interaction. When the groups (test or control) are compared to 
times (4, 8, 12, 18, 24 hours ), as shown by gt in the table, the performance 
between each group for any given time may be assessed. If the interaction (g) 
is statistically significant, this means that one group (e.g. control) had a 
significant change (deterioration) in survival when compared at two different 
times  (e.g. 8 vs. 12 hours), whilst the other group (e.g. test) did not have a 
significant alteration in survival, when compared at these times. This enables 
us to specifically assess the performance of those muscles perfused with 
UWS compared to those without perfusion.  
As shown in Table 8 and highlighted in bold, the interaction (gt) between 
times and groups were statistically significant for 8 vs. 12 hours, 8 vs. 18 
hours and 8 vs. 24 hours.  
 
  
102 
 
102 
In each of these (when 8 hours was compared with 12, 18 and 24 hours 
respectively), the TEST survived better than the CONTROL group viz. there 
were no significant differences in ischaemic survival in the test groups whilst 
there was a difference in survival in the control groups. 
This means that with times beyond 8 hours of cold ischaemia, the stored 
muscle shows statistically significant more deterioration than does the 
perfused muscle, which shows statistically less deterioration at 8, 12, 18 and 
24 hours. 
 
 It is crucial to note that although deterioration occurs in both test and control 
groups at the time intervals above, the deterioration is significantly more in 
the control groups for every time group compared except 4 and 8 hours. For 
time periods less than 8 hours, cold perfusion potentially offers more 
benefits than simple cold storage (as shown on light microscopy). 
 
It would therefore appear that muscle which is simply placed in cold 
storage beyond a cut-off point of 8 hours deteriorates more rapidly than 
muscle which is perfused with cold storage solution and that perfusion of 
muscle has benefit beyond 8 hours.  
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4.4. CLINICAL APPLICATIONS AND FUTURE CONSIDERATIONS  
 
The development of a solution suitable for reliable and possibly even long-
term preservation of explanted tissues has occupied investigators since the 
advent of tissue transplantation. In the field of reconstructive microsurgery 
particularly, a successful protocol for preservation of skin, muscle and 
composite flaps, would be highly desirable.  
 
In the rapidly advancing field of tissue transplantation surgery, it is 
imperative that we explore ways to minimise the deleterious effects of 
ischaemia, storage and reperfusion. Such ways and means would also 
improve the results of limb and digit replantation and may, in fact, allow for 
storage of previously harvested flaps and pave the way for the eventual 
establishment of banks of allograft tissue flaps for use in reconstructive 
surgery.  
 
This study has shown that a significant improvement in survival of ischaemic 
skeletal muscle can be obtained by cold perfusion with oxygenated UW 
solution. Even at 24 hours of ischaemia, this method has resulted in an 
almost two-fold improvement in survival.  
 
In addition to simple “ laboratory relevance” , this study, I believe, has 
important practical and clinical applications to the reconstructive 
microsurgeon. Certain protocols can therefore be advanced.  
 
With regard to all muscle containing parts (muscle- containing amputated 
parts or free tissue transplants), the recommendations are as follows: 
1. all tissue, particularly highly aerobic and vulnerable tissues such 
as muscle, must be subjected to the minimum periods of warm 
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ischaemia, preferably less than 2 hours and definitely less than 4 
hours. In 1946, Clark documented early histologic changes in 
muscles subjected to tourniquet ischaemia after only 2 hours of 
ischaemia. In  this study, 8 hours of cold ischaemia seems to be a 
crucial “ cut-off”  point after which muscle deteriorates rapidly. 
2. for ischaemic intervals less than 8 hours, cold storage is 
imperative i.e. all muscle rendered ischaemic should be cooled. 
For time periods less than 8 hours, is not clear as to which method 
of storage offers more advantages (be it simple cold storage in 
refrigerator at 4 OC or perfusion with cryopreservative solution). 
On electron microscopy, no significant differences in survival 
were seen between the 2 groups after less than 8 hours, yet there 
is a trend in favour of perfusion. When one analyses the overall 
features of ischaemia (on light and electron microscopy 
combined), perfused muscle performs significantly better after 
ischaemic periods as brief as 4 hours.  
3. Beyond 8 hours, a highly significant difference between the 2 
methods has been demonstrated, regardless of which assessment 
is used (LM, EM, or combined).Cryopreservation with cooled, 
oxygenated UWS performed much better than simple cold storage 
and confers distinct survival advantages. This is especially true of 
prolonged periods of ischaemia of up to 24 hours. It is 
recommended that muscle rendered ischaemic for more than 4 
hours and definitely for periods beyond 8 hours, should be 
cryoperfused with UWS. 
 
The clinical implications are obvious. Free tissue transfers using muscle are 
commonplace and transfers usually have warm ischaemic time of 2 to 3 
hours depending on various technical factors. 
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The microsurgeon should limit ischaemic time as far as possible and should 
ensure that recipient vessels are well prepared so that the transplanted muscle 
may be re-anastomosed and the muscle reperfused with minimal delay. 
Furthermore, whilst the muscle is explanted, one should limit the warm 
ischaemic process by topical cooling of the muscle flap. This common-sense 
practice is often overlooked in the clinical setting. As we have demonstrated 
from the studies on warm vs. cold storage, muscle performs much better if 
cooled even if ischaemic time periods are short.  
 The decrease in metabolic rate may have a direct bearing on the functional 
performance of the muscle once transplanted. Although it was beyond the 
scope of this study to analyse the function of the muscle following its 
storage/ perfusion, it is likely that muscle with improved cellular survival 
would function better after replantation. 
Topical cooling continues the overall beneficial effects of hypothermia on 
ischaemic tissue. Traditionally, topical physiological solutions such as 
normal saline or Ringer lactate have been used. In this study, UWS was used 
both topically and as the perfusate with statistical benefit. Again, it was 
beyond the scope of the study to compare the effects of different topical 
cooling agents. Suffice it to say that the crucial ingredients of UWS make it a 
logical choice as a topical cooling agent for muscles subjected to ischaemia 
less than 8 hours or for intra-operative cooling. 
 
With regard replantation surgery of amputated muscle containing parts, 
clinical practice tells us that it is very difficult to establish reperfusion of 
these parts within 8 hours of injury. Delays in accessing the injured victim, 
transporting the patient, admitting, resuscitating and mobilising a 
microsurgical team are generally the norm. This is particularly true in 
patients who have been injured some distance away from a major referral 
centre with microsurgical facilities and expertise.  
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If delays beyond 8 hours are anticipated, this study has conclusively 
demonstrated that cryoperfusion of the amputated part may be prudent.  
In practical terms, the major artery of the amputated part can be rapidly and 
easily cannulated and perfused with UWS. Portable perfusion pumps are 
available and may have a place on long-distance patient transportation, be 
they by road or air. If such pumps are unavailable, perhaps a simple flush 
with UWS may be prudent. 
 
This study has provided important information on several levels, but as with 
any research, unanswered questions remain. A few of these issues are as 
follows and hopefully may be answered by future studies: 
 
1. Would simple flushing achieve similar results as compared to  
   perfusion ? 
2. What is the best method of perfusion – continuous versus pulsatile? 
3. What would the effects be using a more simple solution e.g. Ringer 
lactate or saline? 
4. How would our results perform on a larger series of flaps? 
5. How would other tissue models perform, most importantly, muscle-
containing amputated parts in the human? 
6. How could we relate percentage of muscle damage / overall survival to 
muscle performance and function after replantation? 
7. Can we actually reverse documented ischaemic damage by means of 
perfusion techniques and therefore salvage the “ dying”  cell, preventing it 
from becoming irreversible damaged? 
8. What are the effects of perfusion on the muscle after it has been 
replanted and reperfused – i.e. does prior perfusion affect reperfusion 
injury? 
9. what is the role of oxygenation? 
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4.5. CONCEPT OF THE “ IDEAL”  PERFUSION SOLUTION 
 
Prolonged ischaemia, hypothermic storage and subsequent reperfusion 
represent conditions and stresses which neither tissues nor organs are 
designed to cope with. “ Simple”  crystalloid and even more complex colloids 
such as plasma, may also not be able to cope with these stresses. The 
addition of certain pharmacological agents designed specifically to target 
certain pathways that develop in pathophysiological conditions (ischaemia, 
storage or reperfusion), seem to be very necessary.  
 
The development of advanced tissue preservation solutions needs to be 
supplemented by strategies targeting perfusion phenomena, i.e. oxygen free 
radical generation, neutrophil chemotaxis, migration and degranulation and 
platelet activation.  
 
Several mechanisms of how perfusion preserves tissues generally and 
skeletal muscle specifically, can be postulated.  
First, perfusion may dilute and washout toxic metabolites, prevent sludging 
and thrombus formation. The importance of this, highlighted by the studies 
of Rosen et al (1987) and Marshall et al (1988), has already been discussed 
in Section 1.4. 
 
Second, the perfusate may deliver those substrates that are essential for 
muscle metabolism, particularly after the stress of ischaemia and reperfusion. 
This includes an adequate supply of glucose, oxygen and adenine to support 
the oxidative synthesis of ATP. Finally, the components of the perfusate may 
help to minimise ischaemic damage to cells and target specific 
pathophysiological pathways. 
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There is an inherent difficulty in proposing an “ ideal”  solution due to the 
undoubtedly elaborate nature of these pathways whose complexity if far 
from being understood. The likelihood of “ maximal preservation”  is also 
both organ and model-specific and what may be beneficial in one tissue type 
or animal model, may in fact be detrimental in another. 
 
The rationale for including certain additives has to be based, at present, on 
application of known principles (e.g. the inclusion of a buffer) and on the 
inclusion of agents which have, when tested in isolation in past experiments, 
shown either significant benefit or promise for the preservation of ischaemic 
tissues. Ultimately, the most suitable preservation strategy will depend on a 
trial-and-error approach, since there is little doubt that ischaemia / storage / 
reperfusion / no-reflow, is a complex phenomenon amenable to modulation 
on many fronts.  
 
The benefit of inclusion of any active ingredient in a perfusion solution is 
limited to the period of perfusion and storage. Other limitations include the 
dosage of the active ingredient which differs for any given situation and 
animal model. 
 
This study on the isolated skeletal muscle flap in the rabbit, I believe, has 
provided invaluable information regarding one particular preservation 
protocol in one particular model. It has been shown with statistical validation 
that perfusion of this flap with cooled oxygenated University of Wisconsin 
solution has improved ischaemic survival. As with any experimental study, 
particularly in the field of cryopreservation and transplantation biology, one 
must appreciate the limitations of the investigation.  
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This current study has provided some answers, but also provides a platform 
on which further investigation may be built. Important future research may 
help extend the applicability of this one. 
 
It is increasingly probable that future preservation protocols will be 
inseparably linked to reperfusion and transplantation protocols. An important 
extension of this study would be to investigate those phases which follow 
that of ischaemia and hypothermic storage. The phases of reperfusion 
following subsequent transplantation or reimplantation are important to 
follow, including the impact that prior perfusion has on ultimate survival. 
This may be performed by subjecting the muscle to a known ischaemic 
insult, perfusing the muscle ex-vivo and then re-implanting the muscle and 
assessing muscle damage after a period of reperfusion. 
 
This study points to the need for a new, integrated approach to the field of 
preservation and transplantation or replantation. The many areas of past 
research in perfusion solutions, pharmacological additives and the role of 
normal cells subjected to abnormal environment (e.g. role of neutrophil and 
platelet activation and red cells), need to be brought together in the 
development of comprehensive tissue preservation protocols. The 
development of such protocols will therefore need to reconcile two general 
approaches to one problem.  
 
On the reductionist level, more investigation is needed regarding the 
complex pathways that orchestrate the pathophysiological derangements that 
are at play in the ischaemia/ storage/ reperfusion/ no-reflow scenarios. 
Amongst others, areas that need further investigation include the microcosm 
of the inflammatory mediators, including free radicals and other toxic 
metabolites. 
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On the holistic level, research needs to concentrate on the dynamic interplay 
of the various components of the ischaemia/ storage/ reperfusion/ no-reflow 
scenarios and on how these pathways may be modulated or manipulated by 
pharmacological intervention. We also need to integrate treatments which 
may target individual components.  
 
The future may in fact  bring the elusive  “ holy grail”  closer towards our 
grasp, allowing us to minimise the effects of ischaemia and reperfusion 
injury so as to create a “ reflow phenomenon”  and improve overall survival 
of organs and tissues.  
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CHAPTER 5 - APPENDIX 
 
5.1. LIST OF ABBREVIATIONS 
 
[ ] – concentration of 
ADP – adenosine diphosphate 
AK – adenosine kinease 
AMP – adenosine monophosphate 
ATP – adenosine triphosphate 
C - centigrade 
CsA – cyclosporin A 
EM – electron microscopy 
HES - hydroxyethyl starch  
Hsp 70 - heat shock protein 70  
I-R – ischaemia reperfusion 
LM – light microscopy 
mmHg – millimetres of mercury 
mmol/l – millimole per litre 
mOsm - milliosmoles 
NAD, NADP – nicotinamide adenine dinucleide/ phosphate 
NBT - nitroblue tetrazolium  
PAF – platelet activating factor 
PCO2 – partial pressure of carbon dioxide 
PGI2  -  prostacyclin I2 
PO2 – partial pressure of oxygen 
ROS – reactive oxygen species 
SOD – superoxide dismutase 
TXA2  - thromboxane A2 
UWS – University of Wisconsin solution 
  
112 
 
112 
5.2. ACKNOWLEDGEMENTS: 
 
1. To my family and friends whose enduring love and support has made all 
things possible.  
2. Dr. Morris Ritz, whose depth of thought is matched only by its laterality 
– his directing force allowed this project to develop to fruition. 
3. Dr. Vicky Fabian, one of the project supervisors, whose excellent 
knowledge and superb histopathology skills made this project possible. 
4. Prof. L. Chait, for agreeing to supervise this study and for his wisdom 
and guidance over the years. 
5. This work was supported by the South African Institute for Medical 
Research who generously sponsored all electron and light microscopic 
material.  
6. Mrs. Esther Viljoen  – for her excellent endeavours regarding the 
statistical analysis of this project. 
7. Mrs. Ucelia Norval (Department of Histopathology) and Mrs. G. Norman 
(Department of Electron Microscopy) – their technical advice, continued 
devotion to this work and highly specialised skills were greatly needed and 
appreciated.  
8. Dr. Rene Botha – for generously providing the use of the renal perfusion 
apparatus and donating the University of Wisconsin solution. 
9. Dr. Gavin Norton – for allowing us the use of the physiology laboratory 
and all the necessary apparatus and for his excellent advice regarding the 
physiology of this experimental study. 
10. Dr. J. van Westing – for kindly agreeing to take on the mammoth task of 
commenting on this report and for his excellent input and proof reading 
skills. 
11. Dr. P. Bekker – for his superb advice regarding the statistical planning of 
this project. 
  
113 
 
113 
12. To any other person/s who were involved in this project and who may 
have been unintentionally omitted. 
 
5.3. SUPERVISOR /  ASSOCIATES / CONTRIBUTORS 
 
Supervisor:  Prof. L. Chait, FRCS (1) 
Associates: Dr. M. Ritz, FCS (1) 
                   Dr. Vicky Fabian, FFPath. (2) 
Contributors: Ms. Glenda Norman, MSc(3) 
                      Mrs. Ucelia Norval, BSc (4) 
                      Dr. G Norton,MBBCh, PhD (5) 
                      Dr. P Bekker, PhD (6) 
                      Mrs. E. Viljoen, BSc (maths stats) (6) 
 
(1)  Division of Plastic and Reconstructive Surgery, University of the 
Witwatersrand, Johannesburg, South Africa. 
(2)  Department of Neuropathology, Royal Perth Hospital, Perth, Western 
Australia. 
(3)  Electron Microscopy Unit, Department of Anatomical Pathology, 
University of the Witwatersrand and South African Institute of Medical 
Research, Johannesburg, South Africa.  
(4) Division of Histopathology, Department of Anatomical Pathology, 
University of the Witwatersrand and South African Institute of Medical 
Research, Johannesburg, South Africa. 
(5) Department of Physiology, University of the Witwatersrand Medical 
School, Johannesburg, South Africa. 
(6) Department of Biostatistics, University of the Witwatersrand Medical 
School, Johannesburg, South Africa 
  
114 
 
114 
CHAPTER 6 -   LIST OF REFERENCES 
 
Angel, M.F. et al. Amelioration of secondary ischaemic injury 
by perfusion with UW solution in rat skin flaps. Br. J. Plast. Surg., 
46, 288, 1993. 
 
Angel, M.F. et al. Free radicals: basic concepts concerning their 
chemistry, pathophysiology and relevance to plastic surgery. Plast. 
Recon. Surg.,  79, 990, 1987.  
 
Angel, M.F. et al. Prior elevation of vascular island skin flaps: 
intolerance to ischaemia caused by venous obstruction. J. Recon. 
Microsurg., 5, 2, 1989. 
 
Angel, M.F. et al. The effect of desferroxamine on tolerance to 
secondary ischaemia caused by venous obstruction. Br. J. Plast. 
Surg., 42, 422, 1989. 
 
Ashford Gatley, R.A. & Wilson, G.J. The "border zone" in 
myocardial infarction: an ultrastructural study in the dog using an 
electron-dense blood flow marker. Am. J. Path., 131, 452, 1988. 
 
Barber, W.H. et al. Pulsatile perfusion preservation: early post-
transplant dialysis requirement predicts rapid graft loss. Transplant 
Proc., 22, 446, 1990. 
 
Belkin, M.B. et al. Iloprost infusion decreases skeletal muscle 
ischaemia-reperfusion injury. J. Vasc. Surg., 11, 1, 1990. 
 
 
  
115 
 
115 
Belzer, F.O. & Southard, J.H. Principles of solid-organ preservation 
by cold storage. Transplantation 45, 673, 1988. 
 
Belzer, F.O. et al. 24- and 72- hour preservation of canine kidneys. 
Lancet 2, 536, 1967. 
 
Belzer, F.O., Hoffmann, R.M.& Southard, J.H. Aerobic and 
anaerobic perfusion of canine kidney with a new perfusate. In: Organ 
Preservation- Basic and Applied Aspects, ed. D.E, Pegg, A. 
Jacobsen, A. Halasz, pp 253-260: Lancaster, England. MTP Press, 
1982. 
 
Belzer, F.O. Evaluation of kidney preservation methods. Lancet 1, 
1063, 1973. 
 
Belzer, F.O., Hoffman, R.M., & Southard. Kidney preservation. 
Surg. Clin. N. A. 58., 261, 1978. 
 
Biguzas, M., Jablonski, P., Howden, B, et al. Evaluation of UW 
solution in rat kidney preservation: II. The effect of pharmacological 
additives. Transplantation  49, 1051-1055, 1990. 
 
Blebea, J. et al. Quantitative histochemical evaluation of skeletal 
muscle ischaemia and reperfusion injury. J. Surg. Res., 43, 311, 
1987. 
 
Bonventre, J.V. & Cheung, J.Y. Effects on metabolic acidosis on 
viability of cells exposed to anoxia. Am., J. Physiol., 249, C149-159, 
1985. 
  
116 
 
116 
Bonventre, J.V. & Weinberg, J.M. Kidney preservation ex vivo for 
transplantation. Ann. Rev. Med,. 43, 523, 1992. 
 
Bosco, P.J.& Schweizer, R.T. Use of oxygen radical scavengers on 
autografted pig kidneys after warm ischaemia and 48-hour perfusion 
preservation. Arch. Surg., 123, 601-604, 1988. 
 
Bresticker, M.A. et al. Successful extended lung preservation with 
UW solution. Transplantation 54, 780, 1992. 
 
Brezis, M., Rosen, S., Silva, P. & Epstein, F.H. Renal ischaemia: a 
new perspective. Kidney Int., 26, 375-383, 1984. 
 
Brooks, B. Pathological changes in muscle as a result of disturbances 
of circulation. An experimental study of Volkmann's ischaemic 
paralysis. Arch. Surg., 5, 88, 1922. 
 
Burg, M.B. & Orloff, J. Active cation transport by kidney tubules at 
0 degrees C. Am. J. Physiol., 207, 983-988, 1964. 
 
Carrell, A.  Results of the transplantation of blood vessels, organs, 
and limbs. J. Am. Med. Ass., 51, 1662, 1908. 
 
Carroll, C.M.A., Carroll, S.M., Overgoor, M.L.E., et al. Acute 
ischemic preconditioning of skeletal muscle prior to flap elevation 
augments muscle-flap survival. Plast. Recon. Surg., 100, 58 – 64, 
1997. 
 
  
117 
 
117 
Chachques, J.C., Fabiani, J.N., Perier, P. et al. Reversibility of 
muscular ischemia: a histochemical quantification by the 
nitroblue tetrazolium (NBT) test. Angiology – J. Vasc. Dis., 
(Aug), 493 – 499, 1985. 
 
Chait, L.A., May, J.W., O’ Brien, B.M. et al. The effects of the 
perfusion of various solutions on the no-reflow phenomenon in 
experimental free flaps. Plast. Recon. Surg., 61, 421, 1978. 
 
Chaundry, I.H. Cellular mechanisms in shock and ischaemia and 
their correction. Am. J. Physiol., 254, R117, 1983. 
 
Cikrit, D. et al. Beneficial effects of exogenous ATP on skin flap 
viability. Surg. Forum 35, 578, 1984.  
 
Clarke,W.E. An experimental study of the regeneration of 
mammalian striped muscle. J. Anat., 80, 24, 1946. 
 
Clarke,W.T. Volkmann's ischemic contracture. Canad. Med. J., 54, 
339, 1946. 
 
Clavien, P., Harvey, P.R.C. et al. Preservation and reperfusion 
injuries in liver allografts. An overview and synthesis of current 
studies. Transplantation 53, 957, 1992. 
 
Collins, G.M. et al. Kidney preservation for transplantation: initial 
perfusion and 30 hour ice storage. Lancet 2, 1219, 1969. 
  
118 
 
118 
Cooley, B.C., Tadych, K.L.& Gould, J.S. Perfusion of free flaps with 
heparinized whole blood during ischemic storage. J. Reconstr. 
Microsurg., 6, 49-53, 1990. 
 
Crake, T. & Poole-Wilson, P. Evidence that calcium influx on 
reoxygenation is not due to cell membrane disruption in isolated 
rabbit heart. J. Mol. Cell. Cardiol., 18, 31,1986. 
 
Currie, R.W., Karmazyn, M.& Kingma, J.G. Heat-shock response 
and limitation of tissue necrosis during occlusion/ reperfusion in 
rabbit hearts. Circulation 87, 963 – 971, 1993. 
 
Currin, R.T. et al. Protection by acidotic pH against anoxic cell 
killing in perfused rat liver: evidence for a pH paradox. FASEB J., 5, 
207, 1991. 
 
Currin, R.T., Thurman, R.G.& Lemasters, J.J. Carolina rinse solution  
protects adenosine triphosphate-depleted hepatocytes against lethal 
cell injury. Trans. Proc., 23, 645-647, 1991. 
 
D’ Alessandro, A.M. et al. Organ preservation. Surg. Clin. N. A., 74, 
1083, 1994. 
 
Del Maestro, R.F. An approach to free radicals in medicine and 
biology. Acta Physiol. Scand. [supp.]., 492, 153, 1980. 
 
Donski, P.K., Franklin, J.D., Hurley. J.V.  et al. The effects of 
cooling on experimental free flap survival. Br. J. Plast. Surg.,  33,  
353 - 360, 1980. 
  
119 
 
119 
Douglas, B.K. et al. Beneficial effects of ibuprofen on experimental 
free flaps. Pharmacologic alteration of the no-reflow phenomenon. 
Plast. Recon. Surg., 79, 366, 1987. 
 
Douglas, B.K. et al. Perfusion washout: increasing a microvascular 
free flap tolerance to ischaemia.  J. Recon. Microsurg,. 5, 2, 1989. 
 
Drummond, A.M. & Shiel, A.G. A comparison of perfusates for 24-
hour preservation of ischaemically damaged canine kidneys. Aust. 
N.Z. J. Surg., 44, 183,1974. 
 
Elkadi, H.K., Mardan, A.H., Nghiem, D.D. et al. The role of calcium 
antagonists in the management of renal warm ischaemia. J. Urol., 
141, 974-980, 1989. 
 
Factor, S.M., Cho, S. & Kirk, E.S. Nonspecificity of 
triphenyltetrazolium chloride for the gross diagnosis of acute 
myocardial infarction. Circulation 66, 84, 1981. 
 
Ferwana, O.S. et al. Effect of phosphate-buffered sucrose solution 
upon the initial phase of ischaemic acute renal failure in the rat. Clin. 
Sci., 77, 77, 1989. 
 
Flores, J., Dibona, D. R., Beck, C. H., et al.    The role of cell 
swelling in ischaemic renal damage and the protective effect of 
hypertonic solute. J. Clin. Invest., 51, 118, 1972. 
 
  
120 
 
120 
Fuller, B.J. et al. Free radical damage and organ preservation: fact or 
fiction? A review of the interrelationship between oxidative stress 
and physiological ion disbalance. Cryobiology 25, 377, 1988. 
 
Fuller, B.J. The effects of cooling on mammalian cells. In: Fuller, 
B.J. and Grout, B.W.W. (eds): Clinical Applications of Cryobiology. 
Boca Raton, CRC Press, p1, 1991. 
 
Gao, W. et al. Carolina rinse solution increases survival time 
dramatically after orthotopic liver transplantation in the rat. 
Transplant. Proc., 23, 648, 1991.   
 
Garvin, P.J., Jellinek, M., Morgan, R. & Codd, J.E. Renal cortical 
levels of adenosine triphosphate: restoration after prolonged ischemia 
by in-situ perfusion of ATP-MgCl2. Arch. Surg., 116,  221-224, 
1981. 
 
Gordon, L. et al. Improved preservation of skeletal muscle in 
amputated limbs using pulsatile hypothermic perfusion with 
University of Wisconsin solution. J. Bone Joint Surg., 74A, 1358, 
1992. 
 
Gould, J.S., Sulley, L., O’ Brien  et al. The effects of combined 
cooling and perfusion on experimental free-flap survival in rabbits. 
Plast. Recon. Surg.,  76, 104, 1985. 
 
Gower, J.D., Healing, G., Fuller, B.J. et al. Protection against 
oxidative damage in cold-stored rabbit kidneys by desferroxamine 
and indomethacin. Cryobiology 26, 309-317, 1989. 
  
121 
 
121 
Granger, D.N., Hollworth, M.E. & Parks, D.A. Ischaemia-
reperfusion injury: role of oxygen-derived free radicals. Acta. 
Physiol. Scand. (supp.), 548, 47, 1986. 
 
Green, C.J. & Pegg, D.E. Mechanism of action of “ intracellular”  
renal preservation solutions. World J. Surg., 3, 115-120, 143-144, 
1979. 
 
Green, C.J., Dhami, S., Prasad, S. et al. The effect of desferroxamine 
on lipid peroxidation and survival of ischaemic island skin flaps in 
rats. Br. J. Plast. Surg., 42, 565-569, 1989. 
 
Green, C.J., Healing, G. Lunec, J. et al. Evidence of free radical 
induced damage in rabbit kidneys after simple hypothermic 
preservation and autotransplantation. Transplantation  41, 161-165, 
1986. 
 
Gregory, M.A. & Mars, M. Serial morphological changes in primate 
skeletal myofibres after 3 hours of ischaemia and 24 hours of 
reperfusion. South Af. Med. J.,  81, 473, 1992. 
 
Griffiths, D.L. Volkmann's ischaemic contracture. Br. J. Surg.,  28, 
239, 1940. 
 
Griffiths, R.W. et al. The influence of postoperative pharmacological 
vasodilator agents on the pattern of skin flap necrosis in a 
standardised rat skin flap. Br. J. Plast. Surg., 34, 441, 1981. 
  
122 
 
122 
Guelinckx, P.J. et al. Neurovascular-anastomosed muscle grafts in 
rabbits: functional deficits result from tendon repair. Muscle & Nerve 
11, 745, 1988. 
 
Guerlinckx, P.J. & Faulkner, J.A. Parallel-fibered muscles 
transplanted with neurovascular repair into bipennate muscle sites in 
rabbits. Plast. Recon. Surg., 89, 290, 1992. 
 
Halasz, J et al. Forty-eight kidney preservation; A comparison of 
flushing and ice storage with perfusion. Arch. Surg., 111, 175, 1976. 
 
Harashima, T. & Buncke, H.J. Study of washout solutions for 
microvascular replantation and transplantation. Plast. Recon. Surg., 
56, 542, 1975. 
 
Harman, J.W. A histological study of skeletal muscle in acute 
ischemia Am. J. Path., 23, 551, 1947. 
 
Harris,K., Walker, D.A.G., Mickle, R et al. Metabolic response of 
skeletal muscle to ischemia. Am. J. Physiol., 250, H213-220, 
1986. 
 
Hawkes, J.S. et al. Ischaemic reperfusion injury in pedicle flaps in 
the pig: lack of protective effect of SOD and allopurinol. Br. J. Plast. 
Surg.,  42, 668, 1989.  
 
Henry, M.L. et al. Improved immediate renal allograft function after 
initial simple cold storage. Transplant Proc., 22, 388, 1990. 
 
  
123 
 
123 
Heuer, H.O., Casals-Stenzel, J., Maucebec, G. et al. Pharmacologic 
activity of Bepafant (WEB 2170): a new and selective antagonist of 
platelet activating factor. J. Pharmacol. Exp. Ther., 255, 962-968, 
1990. 
 
Hickey, M.J., Hurley, J.V., Angel, M.F. et al. The response of the 
rabbit rectus femoris muscle to ischemia and reperfusion. J. Surg. 
Res., 53, 369 – 377, 1992. 
 
Hickey, M.J., Knight, K.R., Hurley, J.V. et al. 
Phosphoenolpyruvate / adenosine triphosphate enhances post-
ischemic survival of skeletal muscle. J. Recon. Micro., 11 (6), 
415 – 422, 1995. 
 
Hicks, T.E., Boswick, J.A. & Solomons, C. The effects of perfusion 
on an amputated extremity. J. Trauma 20, 632, 1980. 
 
Higgs, G.A., Cardinal, D.C., Moncada, S. et al. Microvasculatory 
effects of prostacyclin in the hamster cheek pouch. Microvasc, Res., 
18, 245, 1979.  
 
Hoshino, T., Maley, W.R. et al. Ablation of free-radical mediated 
reperfusion injury for the salvage of kidneys taken from non-
heartbeating donors. Transplantation 45, 284, 1988. 
 
Im, M.J. et al. Effect of allopurinol on the survival of hyperemic 
island skin flaps. Plast. Recon. Surg., 73, 276, 1984. 
 
  
124 
 
124 
Jakayanagi, S. & Ogawa,Y. Effects of pentoxifylline on flap survival. 
Plast. Recon. Surg., 65, 763, 1980. 
 
Jamieson, N., Sundberg, P. et al. Preservation of the canine liver for 
24-48 hours using simple cold storage with UW solution. 
Transplant., 46, 517, 1988. 
 
Jepston, P.N. Ischaemic contracture. Ann. Surg., 84, 785, 1926. 
 
Johnson, R.W.G. The current status of continuous preservation for 
renal perfusion. In: Renal Preservation, ed. M. Marberger, K. 
Dreikorn, pp 244-260, Baltimore: Williams and Wilkins. 1983. 
 
Kallerhoff, M. et al. Effects of preservation conditions and 
temperature on tissue acidification in canine kidneys. Transplantation 
39, 485, 1985.  
 
Karnovsky, M.J. A formaldehyde-gluteraldehyde fixative of high 
osmolality for use in electron microscopy. J. Cell Biol., 27, 137A, 
1965. 
 
Kasiske, B.L. et al. Mild hypothermia gives better functional 
preservation than cold or normothermic perfusion of rat kidneys. 
Transplant Proc., 22, 472, 1990. 
 
Katz, A.M. & Reuter, H. Cellular calcium and cardiac cellular death. 
Am. J. Cardiol., 44, 188, 1979. 
 
  
125 
 
125 
Kawabata, H. Et al. Experience with calcium antagonists 
nitrendipine, diltiazem and verapamil and beta2 agonist salbutamol in 
salvaging ischaemic skin flaps in rabbits. Microsurgery 12, 160,1991. 
 
Keppler, D. et al. The relation of leukotrienes to liver injury. 
Hepatology 5, 883, 1985. 
 
Kerrigan, C.L. & Daniel, R.K. Pharmacologic treatment of the failing 
skin flap. Plast. Recon. Surg., 70, 541, 1982. 
 
Kerrigan, C.L. & Stotland, M.A. Ischemia reperfusion injury: a 
review. Microsurg., 14, 165 – 175, 1993. 
 
Khazanchi, R.K. et al. Effect of phosphoenolpyruvate and adenosine 
triphosphate on rabbit skeletal muscle after ischaemia: a preliminary 
biochemical study. Microsurgery 10, 8, 1989. 
 
Knight, K.R., Crabb, D.J.M., Niall, M. et al. Pharmacologic 
modification of blood flow in the rabbit microvasculature with 
prostacyclin and related drugs. Plast. Recon. Surg., 75, 692, 1985. 
 
Knight, K.R., Kawabata, H., Coe, S. et al. Prostacyclin and 
prostanoid modifiers aid ischaemic skin flap survival. J. Surg. Res., 
50, 2, 1991. 
 
Kohout, M., Lepore, D.A., Knight, K.R.  et al. Cool perfusion 
solutions for skin flaps: a new mixture of pharmacological agents 
which improves skin flap viability. Br. J. Plast. Surg.,  48, 132, 1995. 
 
  
126 
 
126 
Kreidstein, M.L. et al. The isolated perfused human skin flap: 
Design, perfusion technique, metabolism and vascular reactivity. 
Plast. Recon. Surg., 87, 4, 1991. 
 
Kucukcelebi, A. & Ozcan, M. The beneficial effect of cyclosporin A 
on the no-reflow phenomenon in rat skin-island flaps. Br. J. Plast. 
Surg., 45, 512-514, 1992. 
 
Kuzon, W.M. et al. Effect of ATP-MgCl on blood flow and vascular 
permeability in rat skin and muscle. Surg. Forum 36, 595, 1985. 
 
Labbe, R., Lindsay, T., Gatley, R. et al. Quantitation of postischemic 
skeletal muscle necrosis: histochemical and radioisotope techniques. 
J. Surg. Res., 44, 45 – 53, 1988. 
 
Lapchinsky, A.G. Recent results of experimental transplantation of 
preserved limbs and kidneys and possible use of this technique in 
clinical practice. Ann. N. Y. Acad. Sci., 87, 539, 1960. 
 
Lee, H.T. & Lineaweaver, W.C. Protection against ischemia-
reperfusion injury of skeletal muscle: role of ischemic 
preconditioning and adenosine pre-treatment. J. Recon. Micro., 12, 
383- 388, 1996. 
 
Lepore, D.A. & Morrison, W.A. Ischemic preconditioning: lack of 
delayed protection against skeletal muscle ischemia –reperfusion. 
Microsurg., 20, 350 – 355, 2000. 
 
  
127 
 
127 
Lepore, D.A., Knight, K.R., Bhattacharya, S. et al. Drug mixture 
which improves survival of ischemic rabbit epigastric skin flaps. 
Microsurg., 15, 685 – 692, 1994. 
 
Levy, M.N. Oxygen consumption and blood flow in the hypothermic 
perfused kidney. Am. J. Physiol., 197, 1111, 1959. 
 
Li, X., Cooley, B., & Gould, J.S. Ex vivo perfusion with 
anticoagulated blood decreases ischemia / reperfusion injury. J. Hand 
Surg., 18A, 629 – 634, 1993.  
 
Magnussen, M. et al. Controversy in organ preservation. Urologic 
Clin. N. A. 3, 491, 1976. 
 
Malis, C.D., Cheung, J.Y., Leaf, A. et al. Effects of verapamil in 
models of acute ischemic renal failure in the rat. Am. J. Physiol.,  
245, F735-742, 1983. 
 
Manson, P.N., Narayan, K.K., Im, M.J. et al. Improved survival in 
free skin flap transfers in rats. Surg., 99, 211 – 214, 1986. 
 
Marshall, V.C., Howden, B.O., Jablonski, P. et al. Analysis of UW 
solution in a rat liver transplant model. Transplant. Proc., 22, 503-
505, 1990. 
 
Marshall, V.C., Jablonski, P., Biguzas, M. et al. University of 
Wisconsin solution for kidney preservation: the impermeant 
components. Transplant. Proc., 23, 651-652, 1991. 
 
  
128 
 
128 
Mathes, S.J. & Nahai, F. Classification of the vascular anatomy of    
muscles: experimental and clinical correlation. Plast. Recon. Surg., 
67, 177, 1981. 
 
Mathes, S.J. & Nahai, F. Classification of the vascular anatomy of 
muscles: experimental and clinical correlation. Plast. Recon. Surg., 
67, 177, 1981. 
 
May, J.W. Jr, Chait, L.A., O’ Brien, B. McC., et al. The no-reflow 
phenomenon in experimental free flaps. Plast. Recon. Surg., 61, 256 
– 267, 1978. 
 
May, J.W. The no-reflow phenomenon in experimental free flaps. 
McAnulty, J.F. et al. Improved survival of kidney preserved for 
seven days with a phospholipase inhibitor. Transplant Proc., 23, 691, 
1991. 
 
McCord, J.M. Oxygen-derived free radicals in postischaemic tissue 
injury.  New Eng. J. Med.,  312, 159, 1985. 
 
Mehl, R.L. et al. Patency of the microcirculation in the traumatically 
amputated limb - A comparison of common perfusates. J. Trauma 4, 
495, 1964. 
 
Mellow, C.G. et al. The effect of thromboxane synthetase inhibition 
on tolerance of skin flaps to secondary ischaemia caused by venous 
obstruction. Plast. Recon. Surg., 86, 2, 1990. 
 
  
129 
 
129 
Monteiro, D. et al. The influence of pentoxifylline on skin flap 
survival. Plast. Recon. Surg., 77, 277, 1986. 
 
Montruccio, G. et al. Role of platelet-activating factor in reperfusion 
injury of rabbit ischaemic heart. Am. J. Path., 137, 71, 1990. 
 
Morris, S.F. et al. Desferroxamine attenuates ischaemic-induced 
reperfusion injury in the skin and muscle of myocutaneous flaps in 
the pig. Plast. Recon. Surg., 92, 120, 1993. 
 
Moukarzel, M., Benoit, G. et al. Non-randomized comparative study 
between University of Wisconsin cold storage and Euro-Collins 
solution in kidney transplantation. Transplantation Proc.,  22, 
2289,1990. 
 
Myers, M.B. & Cherry, G.W. Design of skin flaps to study vascular 
insufficiency - dextran 70 to improve survival in devascularised skin. 
J. Surg. Res., 7(9), 399, 1967. 
 
Nicols, J.C. et al. Inhibition of nonlysosomal calcium-dependent 
proteolysis by glycine during anoxic injury of rat hepatocytes. 
Gastro., 106, 168, 1994. 
 
Nishikawa, H., Manek, S., Fryer , P.R. et al. Reperfusion injury in rat 
adipomyocutaneous flaps: an ultrastructural and microangiographic 
study. Br. J. Plast. Surg., 44, 500-505, 1991. 
 
Ohkawa, M. et al. Studies on the mechanism of beneficial effects of 
ATP-MgCl following ischaemia. Am. J. Physiol., 244, R794, 1983. 
  
130 
 
130 
Paller, M.S., Schnaith, E.J.& Rosenberg, M.E. ATP enhances 
recovery from renal ischaemia by stimulating cellular proliferation. J. 
Am. Soc. Nephrol., 1, 601(Abstr.), 1990. 
 
Pang, C.Y. Ischaemia-induced reperfusion injury in muscle flaps: 
pathogenesis and major source of free radicals. J. Recon. Microsurg., 
6, 1, 1990. 
 
Pang, C.Y. Pharmacological augmentation of skin flap viability: a 
hypothesis to mimic the surgical delay phenomenon or a wishful 
thought. Ann. Plast. Surg., 22, 4, 1989. 
 
Parrat, J.R. Protection of the heart by ischemic preconditioning: 
mechanisms and possibilities for pharmacological intervention. 
Trends Pharmacol Sci., 15, 19-24, 1994. 
 
Pavlock, G.S. et al. Lysosomal enzyme release in hypothermically 
perfused dog kidneys. Cryobiology  21, 521, 1984. 
 
Pegg, D.E., Foreman, J., Hunt, C.J.& Diaper, M.P. The mechanism 
of action of retrograde oxygen persufflation in renal preservation. 
Transplantation  48, 210-217, 1989. 
 
Ploeg, R.J., Goosens, D. et al. Successful 72-hour cold storage of dog 
kidneys with UW solution. Transplantation  46, 191, 1988. 
 
Ploeg, R.J. et al. Effect of preservation solution on results of 
cadaveric kidney transplantation. Lancet  340, 129, 1992. 
 
  
131 
 
131 
Poole-Wilson, P., Harding, D., Bourdillon, P. et al. Calcium out of 
control. J. Mol. Cell. Cardiol., 16, 175, 1984. 
 
Post, S. et al. Role of eicosanoids in reperfusion injury in rat liver 
transplantation. Transplant Proc., 25, 2547, 1993. 
 
Pudupakkam, S., Harris, K.A., Jamieson, W.G. et al. Ischemic 
tolerance in skeletal muscle: role of nitric oxide. Am. J. Physiol., 
275, H94 – 99, 1998. 
 
Risby, T.H., Maley, W. et al. Evidence for free-radical mediated 
lipid peroxidation at reperfusion of human orthotopic liver 
transplants. Surgery 115, 94, 1994. 
 
Rosen, H.M., Slivjak, M.J.& McBreaty, F.X. Preischaemic flap 
washout and its effect on the no-reflow phenomenon. Plast. Recon. 
Surg., 76, 5, 1985. 
 
Rosen, H.M., Slivjak, M.J., McBreaty, F.X. The role of perfusion 
washout in limb revascularization procedures. Plast. Recon. Surg., 
80, 595 – 602, 1987. 
 
Roth, A.G. et al. Augmentation of skin flap survival by parenteral 
pentoxifylline. Br. J. Plast. Surg., 41, 515, 1988. 
 
Sagi, A., Ferder, M., Levens, D.  et al. Improved survival of island 
flaps after prolonged ischaemia by reperfusion with superoxide 
dismutase. Plast. Recon. Surg., 77,  639 – 644,  1986. 
 
  
132 
 
132 
Sawhney, C.P. The role of heparin in restoring the blood supply in 
ischaemic skin flaps: an experimental study in rabbits. Br. J. Plast. 
Surg., 33, 430,1980. 
 
Shanley, P.F. et al. Acidosis and hypoxic medullary injury in the 
isolated perfused kidney. Kidney Int., 34, 791, 1988.  
 
Sinaceur, J., Ribiere, C., Nordman, J. & Nordman, R. 
Desferroxamine: a scavenger of superoxide radicals? Biochem. 
Pharmacol., 33, 1693-1694, 1984. 
 
Sjostrom, M., Neglen, P., Friden, J.et al. Human skeletal muscle 
metabolism and morphology after temporary incomplete 
ischemia. Eur. J. Clin. Invest., 12, 69 – 79, 1982. 
  
Slater, T.F. Free radical mechanisms in tissue injury. Biochem. J. 
222, 1, 1984. 
 
Smith, A., Hayes, G., Romaschin, A. et al. The role of extracellular 
calcium in ischaemia / reperfusion injury in skeletal muscle. J. Surg. 
Res., 49, 153 – 156, 1990. 
 
Southard, J.H. & Belzer, F.O. Principles of organ preservation. Surg. 
Rounds (May),  353, 1993. 
 
Southard, J.H. & Belzer, F.O. The University of Wisconsin organ 
preservation solution: components, comparisons and modifications. 
Transplant Rev., 7, 176, 1993. 
 
  
133 
 
133 
Southard, J.H. Temperature effects and cooling. In: Clinical 
Ischaemic Syndromes. Mechanisms and Consequences of Tissue 
Injury, ed. G.B. Zelenock, pp303-325. St Louis: Mosby. 
Southard, J.H., van Gulik, T.M., Armetani, M.S. et al. Important 
components of the UW solution. Transplantation  49, 251, 1990. 
 
Southard,J.H., Lutz, M.F., Armetani, M.S.& Belzer, F.O. Stimulation 
of ATP synthesis in hypothermically perfused dog kidneys by 
adenosine phosphate. Cryobiology 21, 13-19, 1984. 
 
Squifflet, J.P., Pirson, Y., Gianello, P., et al. Safe preservation of 
human renal cadaver transplants by Euro-Collins solution up to 50 
hours. Transplant. Proc., 13, 693-696, 1981. 
 
Stein, H.J., Fayman, M.S., Oosthuizen, M.M.J. et al. Verapamil 
improves survival of rat hyperemic island skin flaps. Surgery  4, 617-
623, 1989. 
 
Suarez Nieto, C. et al. A comparative study on the effect of various 
pharmacological agents on the survival of skin flaps in the rat. Br. J. 
Plast. Surg., 45, 113, 1992. 
 
Suzuki, S. et al. Involvement of reactive oxygen species in post-
ischaemic flap necrosis and its prevention by antioxidants. Br. J. 
Plast. Surg.,  44,130, 1991. 
 
Swanson, D.K. Pasaoglu, I. et al. Improved heart preservation with 
UW preservation solution. J. Heart Transplant,. 7, 456,1988. 
 
  
134 
 
134 
Swartz, W.M. et al. The effect of prolonged ischemia on high energy 
phosphate metabolism in skeletal muscle. Surg. Gyn. Obstet., 147, 
872, 1978. 
 
Tanaka, M., Fujiwara, H., Yamasaki, K. et al. Expression of heat 
shock protein after ischemic preconditioning in rabbit hearts. Jpn. 
Circ. J., 62, 512-516, 1998. 
 
Toutas, C.P. & Bergman,T. Tourniquet ischemia, ultrastructural 
and histochemical observations of ischemic human muscle and of 
monkey muscle and nerve. J. Hand Surg., 2, 31 – 37, 1977. 
  
Tsu-Min Tsai, Jupiter, J.B., Serratoni, F, et al. The effect of 
hypothermia and tissue perfusion on extended myocutaneous flap 
viability. Plast. Recon. Surg., 70, (4), 444 – 454, 1982. 
 
Turk, J.B. et al. The use of a new perfusate in experimental 
microvascular flaps: a threefold increase in ischaemic tolerance. J. 
Recon. Microsurg., 7, 305, 1991. 
 
Usui, M., Sakata, H., Ishii, S. Effect of fluorocarbon perfusion upon 
the preservation of amputated limbs. An Experimental study. J. Bone 
Joint Surg., 67(B), 473-477, 1985. 
 
Vary, T.C., Angelakos, E.T.& Schaffer, S.W. Relationship between 
adenine nucleotide metabolism and irreversible ischaemic tissue 
damage in isolated perfused rat heart. Circ. Res., 45, 218-225, 1979. 
 
  
135 
 
135 
Von Oppell, U.O., Pfeiffer, S., Preiss, P., Dunne, T. et al. 
Endothelial cell toxicity of solid-organ preservation solutions. Ann. 
Thorac. Surg., 50, 902-910, 1990. 
 
Walker, P. Pathophysiology of acute skeletal muscle ischemia. Cand. 
J. Surg., 29(5), 340, 1986. 
 
Waugh, M, Pantazi, G, Romeo, R. et al. Cold storage of rat 
skeletal muscle free flaps and pre-ischemic perfusion with 
modified UW solution. Microsurgery 20, 343 – 349, 2000. 
   
Weinberg, H. & Song, Y. Vascular island skin flap tolerance to warm 
ischaemia. An analysis by perfusion fluorometry. Plast. Recon. Surg., 
73, 952, 1984. 
 
Weinberg, J.M. Oxygen deprivation-induced injury to isolated rabbit 
kidney tubules. J. Clin. Invest., 76, 1193, 1985. 
 
Wheater, P.R., Burkitt, H.G. & Daniels, V.G. In: Functional 
Histology. Chap.5, pp 64-75: Churchill Livingstone, London,1979. 
 
Whetel, T.P., Stevenson, T.R. et al. The effect of ischaemic 
preconditioning on the recovery of skeletal muscle following 
tourniquet ischaemia. Plast. Recon. Surg., 100, 1767,1997. 
 
Winchell, R.J. & Halasz, N.A. Lack of effect of oxygen-radical 
scavenging systems in the preserved reperfused rabbit kidney. 
Transplantation  48, 393, 1989. 
 
  
136 
 
136 
Yellon, D.M., Baxter, G.F., Garcia-Dorado, D et al, Ischemic 
preconditioning: present position and future directions. Cardiovasc. 
Res., 37, 21- 33, 1998. 
 
Yokoyama, K., Kimura, M & Itoman, M. Rat whole-limb 
viability after cold immersion using University of Wisconsin 
solution and Euro-Collins solutions. Transplant., 62 (7), 884 – 
888, 1996. 
 
Zimmerman, T.J., Sasaki, G.H.& Khattab, S. Improved ischaemic 
island skin flap survival with continuous intra-arterial infusion of 
ATP-MgCl and superoxide dismutase: a rat model. Ann. Plast. Surg., 
18,  218 - 223, 1987. 
